View Filing Data

Document and Entity Information	12 Months Ended
Document and Entity Information	Dec. 31, 2015 USD ($) shares
Document and Entity Information [Abstract]
Entity Registrant Name	Roper Technologies Inc
Entity Central Index Key	0000882835
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float \| $	$ 16,931,595,935
Entity Common Stock, Shares Outstanding \| shares	101,064,624
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	FY
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2015

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
ASSETS:
Cash and cash equivalents	$ 778,511	$ 610,430
Accounts receivable, net	488,271	511,538
Inventories, net	189,868	193,766
Deferred taxes	0	54,199
Unbilled Receivables	122,042	96,409
Other current assets	39,355	45,763
Total current assets	1,618,047	1,512,105
Property, plant and equipment, net	105,510	110,876
Goodwill	5,824,726	4,710,691
Other intangible assets, net	2,528,996	1,978,729
Deferred taxes	31,532	27,496
Other assets	59,554	60,288
Total assets	10,168,365	8,400,185
LIABILITIES AND STOCKHOLDERS' EQUITY:
Accounts payable	139,737	143,847
Accrued Compensation	119,511	117,374
Deferred revenue	267,030	190,953
Other Accrued Liabilities, Current	168,513	160,738
Income taxes payable	18,532	0
Deferred taxes	0	3,943
Current portion of long-term debt, net	6,805	11,092
Total current liabilities	720,128	627,947
Long-term debt, net of current portion	3,264,417	2,190,282
Deferred taxes	810,856	735,826
Other liabilities	74,017	90,770
Total liabilities	4,869,418	3,644,825
Commitments and contingencies (Note 12)
Stockholders' equity:
Common stock	1,028	1,021
Additional paid-in capital	1,419,262	1,325,338
Retained earnings	4,110,530	3,520,201
Accumulated other comprehensive earnings	(212,779)	(71,927)
Treasury stock	(19,094)	(19,273)
Total stockholders' equity	5,298,947	4,755,360
Total liabilities and stockholders' equity	$ 10,168,365	$ 8,400,185

Consolidated Balance Sheets Parenthetical - $ / shares	Dec. 31, 2015	Dec. 31, 2014
CONSOLIDATED BALANCE SHEETS [Abstract]
Preferred stock, par value (dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	1,000	1,000
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	350,000	350,000
Common stock, shares issued (in shares)	102,795	102,069
Common stock, outstanding (in shares)	100,870	100,126
Treasury stock, shares (in shares)	1,925	1,943

Consolidated Statements of Earnings - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Consolidated Statements of Earnings [Abstract]
Net sales	$ 3,582,395	$ 3,549,494	$ 3,238,128
Cost of sales	1,417,749	1,447,595	1,355,200
Gross profit	2,164,646	2,101,899	1,882,928
Selling, general and administrative expenses	1,136,728	1,102,426	1,040,567
Income from operations	1,027,918	999,473	842,361
Interest expense	84,225	78,637	88,039
Loss on extinguishment of debt	0	0	0
Other income, net	58,652	620	(192)
Earnings before income taxes	1,002,345	921,456	754,130
Income taxes	306,278	275,423	215,837
Net earnings	$ 696,067	$ 646,033	$ 538,293
Earnings per share:
Basic (in dollars per share)	$ 6.92	$ 6.47	$ 5.43
Diluted (in dollars per share)	$ 6.85	$ 6.40	$ 5.37
Weighted average common shares outstanding:
Basic (in shares)	100,616	99,916	99,123
Diluted (in shares)	101,597	100,884	100,209
Dividends declared per common share (in dollars per share)	$ 1.05	$ 0.85	$ 0.70

Consolidated Statements of Comprehensive Income (unaudited) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net earnings	$ 696,067	$ 646,033	$ 538,293
Other comprehensive income/(loss), net of tax:
Foreign currency translation adjustments	(139,789)	(115,010)	(15,454)
Unrecognized Pension Gain	(1,063)	0	0
Total other comprehensive income/(loss), net of tax	(140,852)	(115,010)	(15,454)
Comprehensive income	$ 555,215	$ 531,023	$ 522,839

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Earnings [Member]	Treasury Stock [Member]	Total
Beginning Balance at Dec. 31, 2012	$ 1,006	$ 1,158,001	$ 2,489,858	$ 58,537	$ (19,676)	$ 3,687,726
Beginning Balance (in shares) at Dec. 31, 2012	98,604,000
Net earnings	$ 0	0	538,293	0	0	538,293
Stock option exercises	$ 4	23,995	0	0	0	23,999
Stock option exercises (in shares)	434
Treasury stock sold	$ 0	2,248	0	0	201	2,449
Treasury stock sold (in shares)	20
Currency translation adjustments, net of tax	$ 0	0	0	(15,454)	0	(15,454)
Stock based compensation	0	53,417	0	0	0	53,417
Restricted stock activity	$ 3	(16,046)	0	0	0	(16,043)
Restricted stock activity (in shares)	254
Stock option tax benefit, net of shortfalls	$ 0	16,000	0	0	0	16,000
Conversion of senior subordinated convertible notes	$ 0	(8,382)	0	0	0	(8,382)
Conversion of senior subordinated convertible notes (in shares)	0
Dividends declared	$ 0	0	(68,955)	0	0	(68,955)
Ending Balance at Dec. 31, 2013	1,013	1,229,233	2,959,196	43,083	(19,475)	$ 4,213,050
Ending Balance (in shares) at Dec. 31, 2013						99,312
Net earnings	0	0	646,033	0	0	$ 646,033
Stock option exercises	$ 6	32,517	0	0	0	32,523
Stock option exercises (in shares)	581
Treasury stock sold	$ 0	2,549	0	0	202	2,751
Treasury stock sold (in shares)	20
Currency translation adjustments, net of tax	$ 0	0	0	(115,010)	0	(115,010)
Stock based compensation	0	63,025	0	0	0	63,025
Restricted stock activity	$ 2	(22,064)	0	0	0	(22,062)
Restricted stock activity (in shares)	213
Stock option tax benefit, net of shortfalls	$ 0	21,481	0	0	0	21,481
Conversion of senior subordinated convertible notes	$ 0	(1,403)	0	0	0	(1,403)
Conversion of senior subordinated convertible notes (in shares)	0
Dividends declared	$ 0	0	(85,028)	0	0	(85,028)
Ending Balance at Dec. 31, 2014	1,021	1,325,338	3,520,201	(71,927)	(19,273)	$ 4,755,360
Ending Balance (in shares) at Dec. 31, 2014						100,126
Net earnings	0	0	696,067	0	0	$ 696,067
Stock option exercises	$ 4	33,002	0	0	0	33,006
Stock option exercises (in shares)	402
Treasury stock sold	$ 0	2,710	0	0	179	2,889
Treasury stock sold (in shares)	18
Currency translation adjustments, net of tax	$ 0	0	0	(139,789)	0	(139,789)
Stock based compensation	0	61,766	0	0	0	61,766
Restricted stock activity	$ 3	(14,697)	0	0	0	(14,694)
Restricted stock activity (in shares)	324
Stock option tax benefit, net of shortfalls	$ 0	22,175	0	0	0	22,175
Conversion of senior subordinated convertible notes	0	(11,032)	0	0	0	$ (11,032)
Conversion of senior subordinated convertible notes (in shares)						0
Deferred Pension Gain	0	0	0	(1,063)	0	$ (1,063)
Dividends declared	0	0	(105,738)	0	0	(105,738)
Ending Balance at Dec. 31, 2015	$ 1,028	$ 1,419,262	$ 4,110,530	$ (212,779)	$ (19,094)	$ 5,298,947
Ending Balance (in shares) at Dec. 31, 2015						100,870

Consolidated Statements of Changes in Stockholders' Equity Parenthetical - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Consolidated Statements of Changes in Stockholders' Equity [Abstract]
Currency translation adjustments, tax	$ 6,658	$ 3,916	$ 2,406
Conversion of senior subordinated convertible notes, tax	$ 2,094
Dividends declared (in dollars per share)	$ 1.05	$ 0.85	$ 0.70

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net earnings	$ 696,067	$ 646,033	$ 538,293
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property, plant and equipment	38,185	40,890	37,756
Amortization of intangible assets	166,076	156,394	151,434
Amortization of deferred financing costs	4,136	4,003	3,918
Non-cash stock compensation	61,766	63,027	53,133
Gain (Loss) on Disposition of Business	(70,860)	0	0
Changes in operating assets and liabilities, net of acquired businesses:
Accounts receivable	52,597	(404)	32,800
Inventories	(1,150)	6,349	(12,687)
Unbilled Receivables	(21,844)	(10,305)	(14,754)
Accounts payable and accrued liabilities	(153)	(20,455)	23,305
Income taxes payable	3,069	(46,619)	(6,427)
Other, net	936	1,528	(4,218)
Cash provided by operating activities	928,825	840,441	802,553
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	(1,762,883)	(305,379)	(1,074,413)
Capital expenditures	(36,260)	(37,644)	(42,528)
Proceeds from Divestiture of Businesses	105,624	0	0
Proceeds from sale of assets	1,126	1,506	2,174
Other, net	(5,939)	(6,588)	(1,096)
Cash used in investing activities	(1,698,332)	(348,105)	(1,115,863)
Cash flows from financing activities:
Proceeds from senior notes	900,000	0	800,000
Payment of senior notes	0	0	(500,000)
Proceeds from (Repayments of) Lines of Credit	180,000	(250,000)	150,000
Principal payments on convertible notes	(4,006)	(561)	(3,702)
Debt issuance costs	(8,044)	0	(7,717)
Cash dividends to stockholders	(100,334)	(79,859)	(49,092)
Treasury stock sales	2,889	2,751	2,449
Stock award tax excess windfall benefit	22,228	21,081	11,709
Proceeds from stock based compensation, net	18,312	10,463	7,944
Redemption Premium Convertible Debt	(13,126)	(1,518)	(9,124)
Other	(1,677)	(461)	1,166
Cash used in financing activities	996,242	(298,104)	403,633
Effect of foreign currency exchange rate changes on cash	(58,654)	(43,522)	(1,193)
Net increase in cash and cash equivalents	168,081	150,710	89,130
Cash and cash equivalents, beginning of year	610,430	459,720	370,590
Cash and cash equivalents, end of year	778,511	610,430	459,720
Cash paid for:
Interest	79,225	74,446	94,648
Income taxes, net of refunds received	280,801	300,969	210,540
Noncash investing activities:
Fair value of assets, including goodwill	1,876,984	324,717	1,275,827
Liabilities assumed	(114,101)	(19,338)	(201,414)
Cash paid, net of cash acquired	$ 1,762,883	$ 305,379	$ 1,074,413

Summary of Accounting Policies

12 Months Ended

Dec. 31, 2015

Summary of Accounting Policies [Abstract]

Summary of Accounting Policies [Text Block]

(1)	Summary of Accounting Policies

Basis of Presentation - Effective April 24, 2015, Roper Industries, Inc. changed its name to Roper Technologies, Inc. in order to reflect its continued evolution to a diversified technology company.

These financial statements present consolidated information for Roper Technologies, Inc. and its subsidiaries ("Roper" or the "Company"). All significant intercompany accounts and transactions have been eliminated. The Company has a minority investment which is not consolidated in its results. The original investment, made in 2007, was $11.5 million. During the year ended December 31, 2015, the Company determined, based on deterioration in earnings performance, that impairment of the investment was likely, and performed an estimated fair value calculation using an earnings multiples methodology. The resulting value was determined to be $2 million, generating an impairment loss of $9.5 million which was reported as Other income/(expense) in the consolidated statement of earnings.

The December 31, 2014 consolidated balance sheet has been adjusted due to the retrospective early adoption of an accounting standard update ("ASU") which requires that Roper's senior notes be shown net of debt issuance costs. The Other assets and Long-term debt, net of current portion line items on the December 31, 2014 consolidated balance sheet were reduced by $13 million.

The Company also early adopted the provisions of an ASU requiring deferred tax liabilities and assets to be classified as noncurrent in the consolidated balance sheet. The ASU allowed for early adoption as of the beginning of an interim or annual reporting period, as well as the option to be applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. The Company elected to adopt on a prospective basis in the fourth quarter of 2015. No prior periods were adjusted.

Nature of the Business - Roper is a diversified technology company. The Company operates businesses that design and develop software (both license and software-as-a-service) and engineered products and solutions for a variety of niche end markets; including healthcare, transportation, food, energy, water, education and academic research.

Accounts Receivable - Accounts receivable are stated net of an allowance for doubtful accounts and sales allowances of $12.4 million and $13.7 million at December 31, 2015 and 2014, respectively. Outstanding accounts receivable balances are reviewed periodically, and allowances are provided at such time that management believes it is probable that an account receivable is uncollectible. The returns and other sales credit allowance is an estimate of customer returns, exchanges, discounts or other forms of anticipated concessions and is treated as a reduction in revenue.

Cash and Cash Equivalents - Roper considers highly liquid financial instruments with remaining maturities at acquisition of three months or less to be cash equivalents. Roper had no cash equivalents at December 31, 2015 and $40 million at December 31, 2014.

Contingencies - Management continually assesses the probability of any adverse judgments or outcomes to its potential contingencies. Disclosure of the contingency is made if there is at least a reasonable possibility that a loss or an additional loss may have been incurred. In the assessment of contingencies as of December 31, 2015, management concluded that no accrual was necessary and that there were no matters for which there was a reasonable possibility of a material loss.

Earnings per Share - Basic earnings per share were calculated using net earnings and the weighted-average number of shares of common stock outstanding during the respective year. Diluted earnings per share were calculated using net earnings and the weighted-average number of shares of common stock and potential common stock outstanding during the respective year. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of the Company's common stock. The effects of potential common stock were determined using the treasury stock method (in thousands):

	Years ended December 31,
	2015		2014		2013
Basic weighted-average shares outstanding		100,616		99,916		99,123
Effect of potential common stock:
Common stock awards		887		816		891
Senior subordinated convertible notes		94		152		195
Diluted weighted-average shares outstanding		101,597		100,884		100,209

As of and for the years ended December 31, 2015, 2014 and 2013, there were 618,220, 764,333 and 614,850 outstanding stock options, respectively, that were not included in the determination of diluted earnings per share because doing so would have been antidilutive.

Estimates - The preparation of financial statements in conformity with generally accepted accounting principles in the United States ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

Foreign Currency Translation and Transactions - Assets and liabilities of subsidiaries whose functional currency is not the U.S. dollar were translated at the exchange rate in effect at the balance sheet date, and revenues and expenses were translated at average exchange rates for the period in which those entities were included in Roper's financial results. Translation adjustments are reflected as a component of other comprehensive income. Foreign currency transaction gains and losses are recorded in the consolidated statement of earnings as other income/(expense). The gain or loss included in pre-tax income was a net loss of $0.7 million for the year ended December 31, 2015, a net gain of $0.2 million for the year ended December 31, 2014 and a net loss of $3.9 million for the year ended December 31, 2013.

Goodwill and Other Intangibles - Roper accounts for goodwill in a purchase business combination as the excess of the cost over the estimated fair value of net assets acquired. Business combinations can also result in other intangible assets being recognized. Amortization of intangible assets, if applicable, occurs over their estimated useful lives. Goodwill, which is not amortized, is tested for impairment on an annual basis (or an interim basis if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value). When testing goodwill for impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the estimated fair value of a reporting unit is less than its carrying amount. If the Company elects to perform a qualitative assessment and determines that an impairment is more likely than not, then performance of the two-step quantitative impairment test is required. The first step of the quantitative process utilizes both an income approach (discounted cash flows) and a market approach consisting of a comparable public company earnings multiples methodology to estimate the fair value of a reporting unit. To determine the reasonableness of the estimated fair values, the Company reviews the assumptions to ensure that neither the income approach nor the market approach provides significantly different valuations. If the estimated fair value exceeds the carrying value, no further work is required and no impairment loss is recognized. If the carrying value exceeds the estimated fair value, the goodwill of the reporting unit is potentially impaired and then the second quantitative step would be completed in order to measure the impairment loss by calculating the implied fair value of goodwill by deducting the fair value of all tangible and intangible net assets (including unrecognized intangible assets) of the reporting unit from the fair value of the reporting unit. If the implied fair value of goodwill is less than the carrying value of goodwill, a non-cash impairment loss is recognized.

When performing the quantitative assessment, key assumptions used in the income and market methodologies are updated when the analysis is performed for each reporting unit. Various assumptions are utilized including forecasted operating results, strategic plans, economic projections, anticipated future cash flows, the weighted-average cost of capital, comparable transactions, market data and earnings multiples. The assumptions that have the most significant effect on the fair value calculations are the anticipated future cash flows, discount rates, and the earnings multiples. While the Company uses reasonable and timely information to prepare its cash flow and discount rate assumptions, actual future cash flows or market conditions could differ significantly resulting in future impairment charges related to recorded goodwill balances.

Roper has 32 reporting units with individual goodwill amounts ranging from zero to $1.2 billion. In 2015, the Company performed its annual impairment test in the fourth quarter for all reporting units. The Company conducted its analysis qualitatively and assessed whether it was more likely than not that the respective fair value of these reporting units was less than the carrying amount. The Company determined that impairment of goodwill was not likely in 29 of its reporting units and thus was not required to perform a quantitative analysis for these reporting units. For the remaining three reporting units, the Company performed its quantitative analysis and concluded that the fair value of each of these three reporting units was in excess of its carrying value, with no impairment indicated as of December 31, 2015. Negative industry or economic trends, disruptions to its business, actual results significantly below expected results, unexpected significant changes or planned changes in the use of the assets, divestitures and market capitalization declines may have a negative effect on the fair value of Roper's reporting units.

The following events or circumstances, although not comprehensive, would be considered to determine whether interim testing of goodwill would be required:

●

a significant adverse change in legal factors or in the business climate;

●

an adverse action or assessment by a regulator;

●

unanticipated competition;

●

a loss of key personnel;

●

a more-likely-than-not expectation that a reporting unit or a significant portion of a reporting unit will be sold or otherwise disposed of;

●

the testing for recoverability under the Impairment or Disposal of Long-Lived Assets of a significant asset group within a reporting unit; and

●

recognition of a goodwill impairment loss in the financial statements of a subsidiary that is a component of a reporting unit.

Business combinations can also result in other intangible assets being recognized. Amortization of intangible assets, if applicable, occurs over their estimated useful lives. Trade names that are determined to have an indefinite useful economic life are not amortized, but separately tested for impairment during the fourth quarter of the fiscal year or on an interim basis if an event occurs that indicates the fair value is more likely than not below the carrying value. Roper first qualitatively assesses whether the existence of events or circumstances leads to a determination that it is more likely than not that the estimated fair value of a reporting unit is less than its carrying amount. If necessary, Roper conducts a quantitative review using the relief-from-royalty method, which management believes to be an acceptable methodology due to its common use by valuations specialists in determining the fair value of intangible assets. This methodology assumes that, in lieu of ownership, a third party would be willing to pay a royalty in order to exploit the related benefits of these assets. The fair value of each trade name is determined by applying a royalty rate to a projection of net sales discounted using a risk adjusted rate of capital. Each royalty rate is determined based on the profitability of the reporting unit to which it relates and observed market royalty rates. Sales growth rates are determined after considering current and future economic conditions, recent sales trends, discussions with customers, planned timing of new product launches or other variables. Reporting units resulting from recent acquisitions generally represent the highest risk of impairment, which typically decreases as the businesses are integrated into Roper's enterprise and positioned for improved future sales growth.

The assessment of fair value for impairment purposes requires significant judgments to be made by management. Although forecasts are based on assumptions that are considered reasonable by management and consistent with the plans and estimates management uses to operate the underlying businesses, there is significant judgment in determining the expected results attributable to the reporting units. Changes in estimates or the application of alternative assumptions could produce significantly different results. No impairment resulted from the annual reviews performed in 2015.

Roper evaluates whether there has been an impairment of identifiable intangible assets with definite useful economic lives, or of the remaining life of such assets, when certain indicators of impairment are present. In the event that facts and circumstances indicate that the cost or remaining period of amortization of any asset may be impaired, an evaluation of recoverability would be performed. If an evaluation is required, the estimated future gross, undiscounted cash flows associated with the asset would be compared to the asset's carrying amount to determine if a write-down to fair value or a revision in the remaining amortization period is required.

Impairment of Long-Lived Assets - The Company determines whether there has been an impairment of long-lived assets, excluding goodwill and identifiable intangible assets, that are determined to have indefinite useful economic lives, when certain indicators of impairment are present. In the event that facts and circumstances indicate that the cost or life of any long-lived assets may be impaired, an evaluation of recoverability would be performed. If an evaluation is required, the estimated future gross, undiscounted cash flows associated with the asset would be compared to the asset's carrying amount to determine if a write-down to fair value or revision to remaining life is required. Future adverse changes in market conditions or poor operating results of underlying long-lived assets could result in losses or an inability to recover the carrying value of the long-lived assets that may not be reflected in the assets' current carrying value, thereby possibly requiring an impairment charge or acceleration of depreciation or amortization expense in the future.

Income Taxes - Roper is a U.S.-based multinational company and the calculation of its worldwide provision for income taxes requires analysis of many factors, including income tax systems that vary from country to country, and the United States' treatment of non-U.S. earnings. The Company provides U.S. income taxes for unremitted earnings of foreign subsidiaries that are not considered permanently reinvested overseas. As of December 31, 2015, the amount of earnings of foreign subsidiaries that the Company considers permanently reinvested and for which deferred taxes have not been provided was approximately $1.25 billion. Because of the availability of U.S. foreign tax credits, it is not practicable to determine the U.S. federal income tax liability that would be payable if such earnings were not reinvested indefinitely.

Although it is the Company's intention to permanently reinvest these earnings indefinitely there are certain events that would cause these earnings to become taxable. These events include, but are not limited to, changes in U.S. tax laws, dividends paid between foreign subsidiaries in the absence of Section 954(c)(6) of the Internal Revenue Code of 1986, as amended ("IRC"), foreign subsidiary guarantees of U.S. parent debt and the liquidation of foreign subsidiaries or actual distributions by foreign subsidiaries into a U.S. affiliate.

The Company early adopted the provisions of an ASU requiring deferred tax liabilities and assets to be classified as noncurrent in the consolidated balance sheet. The ASU allowed for early adoption as of the beginning of an interim or annual reporting period, as well as the option to be applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. The Company elected to adopt on a prospective basis in the fourth quarter of 2015. No prior periods were adjusted.

The Company recognizes in the consolidated financial statements only those tax positions determined to be "more likely than not" of being sustained upon examination based on the technical merits of the positions. Interest and penalties related to unrecognized tax benefits are classified as a component of income tax expense.

The Company records a valuation allowance to reduce its deferred tax assets if, based on the weight of available evidence, both positive and negative, for each respective tax jurisdictions, it is more likely than not that some portion or all of such deferred tax assets will not be realized. Available evidence which is considered in determining the amount of valuation allowance required includes, but is not limited to, the Company's estimate of future taxable income and any applicable tax-planning strategies.

Certain assets and liabilities have different bases for financial reporting and income tax purposes. Deferred income taxes have been provided for these differences at the tax rates expected to be paid.

Interest Rate Risk - The Company manages interest rate risk by maintaining a combination of fixed- and variable-rate debt, which may include interest rate swaps to convert fixed-rate debt to variable-rate debt, or to convert variable-rate debt to fixed-rate debt. Interest rate swaps are recorded at fair value in the balance sheet as an asset or liability, and the changes in fair values of both the swap and the hedged item are recorded as interest expense in current earnings. There were no interest rate swaps outstanding at December 31, 2015.

Inventories - Inventories are valued at the lower of cost or market. Cost is determined using the first-in, first-out method. The Company writes down its inventory for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions.

Other Comprehensive Income - Comprehensive income includes net earnings and all other non-owner sources of changes in a company's net assets.

Product Warranties - The Company sells certain of its products to customers with a product warranty that allows customers to return a defective product during a specified warranty period following the purchase in exchange for a replacement product, repair at no cost to the customer or the issuance of a credit to the customer. The Company accrues its estimated exposure to warranty claims based upon current and historical product sales data, warranty costs incurred and any other related information known to the Company.

Property, Plant and Equipment and Depreciation and Amortization - Property, plant and equipment is stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided for using principally the straight-line method over the estimated useful lives of the assets as follows:

Buildings	20-30 years
Machinery	8-12 years
Other equipment	3-5 years

Recently Released Accounting Pronouncements - The Financial Accounting Standards Board ("FASB") establishes changes to accounting principles under GAAP in the form of accounting standards updates to the FASB's Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. Any ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company's results of operations, financial position or cash flows.

In September 2015, the FASB issued an update providing guidance to simplify the accounting for measurement period adjustments. This update, effective for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years, requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The Company does not expect the update to have a material impact on its results of operations, financial condition or cash flows.

In July 2015, the FASB issued an update providing guidance to simplify the measurement of inventory. This update, effective for fiscal years beginning after December 15, 2016, requires that inventory within the scope of the update be measured at the lower of cost and net realizable value. The Company does not expect the update to have a material impact on its results of operations, financial condition or cash flows.

In April 2015, the FASB issued an update providing guidance to determine whether the fee paid by an entity for a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a software license, then the software license element of the arrangement should be accounted for consistently with the acquisition of other software licenses. A cloud computing arrangement that does not include a software license should be accounted for as a service contract. The update is effective for annual periods beginning after December 15, 2015, and may be adopted prospectively or retrospectively. The Company does not expect this update to have a material impact on its results of operations, financial condition or cash flows.

In June 2014, the FASB issued an update to the accounting for stock compensation. These updates, effective for fiscal years beginning after December 15, 2015, modify the accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. The Company does not expect this update to have an impact on its results of operations, financial condition or cash flows.

In May 2014, the FASB issued updates on accounting and disclosures for revenue from contracts with customers. These updates, effective for annual reporting periods after December 15, 2017, create a single, comprehensive revenue recognition model for all contracts with customers. The model is based on changes in contract assets (rights to receive consideration) and liabilities (obligations to provide a good or service). Revenue will be recognized based on the satisfaction of performance obligations, which occurs when control of a good or service transfers to a customer. The Company is evaluating the impact of these updates on its results of operations, financial condition and cash flows.

Research and Development - Research and development ("R&D") costs include salaries and benefits, rents, supplies, and other costs related to products under development. Research and development costs are expensed in the period incurred and totaled $164.2 million, $147.9 million and $145.7 million for the years ended December 31, 2015, 2014 and 2013, respectively.

Revenue Recognition - The Company recognizes revenue when all of the following criteria are met:

●

persuasive evidence of an arrangement exists;

●

delivery has occurred or services have been rendered;

●

the seller's price to the buyer is fixed or determinable; and

●

collectibility is reasonably assured.

In addition, the Company recognizes revenue from the sale of product when title and risk of loss pass to the customer, which is generally when product is shipped. The Company recognizes revenue from services when such services are rendered or, if applicable, upon customer acceptance. Revenues under certain relatively long-term and relatively large-value construction and software projects are recognized under the percentage-of-completion method using the ratio of costs incurred to total estimated costs as the measure of performance. The Company recognized revenues of $253 million, $266 million and $205 million for the years ended December 31, 2015, 2014 and 2013, respectively, using this method. Estimated losses on any projects are recognized as soon as such losses become known.

Capitalized Software - The Company accounts for capitalized software under applicable accounting guidance which, among other provisions, requires capitalization of certain internal-use software costs once certain criteria are met. Overhead, general and administrative and training costs are not capitalized. Capitalized software balances, net of accumulated amortization, were $4.6 million and $4.7 million at December 31, 2015 and 2014, respectively.

Stock-Based Compensation - The Company recognizes expense for the grant date fair value of its employee stock awards on a straight-line basis (or, in the case of performance-based awards, on a graded basis) over the employee's requisite service period (generally the vesting period of the award). The fair value of option awards is estimated using the Black-Scholes option valuation model. The Company presents the cash flows resulting from the tax benefits arising from tax deductions in excess of the compensation cost recognized for stock award exercises (excess tax benefits) as financing cash flows.

Business Acquisitions

12 Months Ended

Dec. 31, 2015

Business Acquisitions [Abstract]

Business Acquisitions [Text Block]

(2)	Business Acquisitions and Divestitures

2015 Acquisitions – During the year ended December 31, 2015, Roper completed eight business combinations. The results of operations of the acquired companies have been included in Roper's consolidated results since the date of each acquisition. Supplemental pro forma information has not been provided as the acquisitions did not have a material impact on Roper's consolidated results of operations individually or in aggregate.

The results of the following acquisitions are reported in the Medical & Scientific Imaging segment:

·	Strata - On January 21, 2015, Roper acquired 100% of the shares of Strata Decision Technologies LLC ("Strata"), a provider of planning and budget software for health care providers.

·	Softwriters - On February 9, 2015, Roper acquired 100% of the shares of Softwriters Inc., a provider of long-term care pharmacy operating software.

·	Data Innovations - On March 4, 2015, Roper acquired 100% of the shares of Data Innovations LLC, a provider of clinical and blood laboratory middleware.

·	AHP - On September 4, 2015, Roper acquired the assets of Atlantic Health Partners LLC ("AHP"), a group purchasing organization specializing in vaccines for the physician marketplace.

·	Atlas - On October 26, 2015, Roper acquired 100% of the shares of Atlas Database Software Corp. ("Atlas"), a provider of clinical process integration to private and public health sectors.

The results of the following acquisitions are reported in the RF Technology segment:

·	On Center - On July 20, 2015, Roper acquired 100% of the shares of On Center Software LLC ("On Center"), a provider of construction automation technology.

·	RF IDeas - On September 1, 2015, Roper acquired 100% of the shares of RF IDeas, Inc., a provider of proprietary identification card technology solutions.

·	Aderant - On October 21, 2015, Roper acquired 100% of the shares of Aderant Holdings, Inc. ("Aderant"), a provider of comprehensive software solutions for law and other professional services firms.

The aggregate purchase price for the 2015 acquisitions was $1.8 billion, paid in cash. Roper purchased the businesses to expand upon existing software, supply chain and medical platforms.

The Company expensed transaction costs of $5.9 million related to the acquisitions as corporate general and administrative expenses, as incurred.

The Company recorded $1.2 billion in goodwill and $731 million in other identifiable intangibles in connection with the acquisitions; however, purchase price allocations are preliminary pending final intangibles valuations and tax-related adjustments. The majority of the goodwill recorded is not expected to be deductible for tax purposes. Of the $731 million of intangible assets acquired, $51 million was assigned to trade names that are not subject to amortization. The remaining $680 million of acquired intangible assets have a weighted-average useful life of 17 years. The intangible assets that make up that amount include customer relationships of $541 million (19 year weighted-average useful life), unpatented technology of $100 million (8 year weighted-average useful life) and software of $39 million (6 year weighted-average useful life).

Divestiture of Abel - On October 2, 2015, Roper completed the sale of Abel Pumps ("Abel") for $106 million (€95 million), net of cash divested. The pretax gain on the divestiture was $70.9 million, which is reported as Other income/(expense), net on the consolidated statement of earnings. The gain resulted in tax expense of $46 million as well as a future tax benefit of $11 million.

The year to date pretax income of Abel was $5.9 million for the period ended October 2, 2015, and $10.3 million and $9.2 million for the years ended December 31, 2014 and 2013, respectively. Abel was reported in the Industrial Technology segment.

2014 Acquisitions – During the year ended December 31, 2014, Roper completed three business combinations. The results of operations of the acquired companies have been included in Roper's consolidated results since the date of each acquisition. Supplemental pro forma information has not been provided as the acquisitions did not have a material impact on Roper's consolidated results of operations individually or in aggregate.

Roper acquired 100% of the shares of Foodlink Holdings, Inc. ("Foodlink"), Innovative Product Achievements, LLC ("IPA") and Strategic Healthcare Programs Holdings, LLC ("SHP") on July 2, August 5, and August 14, 2014, respectively. The aggregate purchase price was $303 million, paid in cash. Roper purchased the businesses to expand upon existing supply chain and medical platforms. SHP and IPA are reported in the Medical & Scientific Imaging segment, and Foodlink is reported in the RF Technology segment.

The Company expensed transaction costs of $2.8 million related to the acquisitions as corporate general and administrative expenses, as incurred.

The Company recorded $208 million in goodwill and $99 million in other identifiable intangibles in connection with the acquisitions. The majority of the goodwill recorded is not expected to be deductible for tax purposes. Of the $99 million of intangible assets acquired, $7 million was assigned to trade names that are not subject to amortization. The remaining $92 million of acquired intangible assets have a weighted-average useful life of 17 years. The intangible assets that make up that amount include customer relationships of $82 million (19 year weighted-average useful life), unpatented technology of $7 million (6 year weighted-average useful life), software of $2 million (4 year weighted-average useful life) and backlog of $1 million (1 year weighted-average useful life).

2013 Acquisitions – During the year ended December 31, 2013, Roper completed two business combinations. The results of operations of the acquired companies have been included in Roper's consolidated results since the date of each acquisition. Supplemental pro forma information has not been provided as the acquisitions did not have a material impact on Roper's consolidated results of operations individually or in aggregate.

On May 1, 2013, Roper acquired 100% of the shares of Managed Health Care Associates, Inc. ("MHA"), in a $1.0 billion all-cash transaction. MHA is a leading provider of services and technologies to support the diverse and complex needs of alternate site health care providers who deliver services outside of an acute care hospital setting. The acquisition of MHA complements and expands the Company's medical software and services platform. MHA is reported in the Medical & Scientific Imaging segment.

The following table (in thousands) summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition.

Current assets	$	59,813
Identifiable intangibles		465,500
Goodwill		678,183
Other assets		5,798
Total assets acquired		1,209,294
Current liabilities		(24,717	)
Long-term deferred tax liability		(162,503	)
Other liabilities		(6,524	)
Net assets acquired	$	1,015,550

The fair value of current assets acquired also includes an adjustment of $35.0 million for administrative fees related to customer purchases that occurred prior to the acquisition date but not reported to MHA until after the acquisition date. In the ordinary course, these administrative fees are recorded as revenue when reported; however, GAAP accounting for business acquisitions requires the Company to estimate the amount of purchases occurring prior to the acquisition date and record the fair value of the administrative fees to be received from those purchases as an accounts receivable at the date of acquisition. The Company also recorded a fair value liability of $8.6 million included in current liabilities related to corresponding revenue-share obligation owed to customers that generated the administrative fees. Both of these fair value adjustments were fully amortized as of September 30, 2013.

On October 4, 2013, the Company paid $54 million in cash to acquire 100% of the shares of Advanced Sensors, Ltd. ("Advanced Sensors"), a company which manufactures and supports oil-in-water analyzers for the oil and gas industries, in order to expand the Company's product line. Advanced Sensors is reported in the Energy Systems & Controls segment. The Company recorded $28 million in goodwill and $28 million of other identifiable intangibles in connection with the acquisition.

The majority of the goodwill related to the 2013 acquisitions is not expected to be deductible for tax purposes. Of the $493 million of intangible assets acquired in 2013, $28 million was assigned to trade names that are not subject to amortization. The remaining $465 million of acquired intangible assets have a weighted-average useful life of approximately 19 years. The intangible assets that make up that amount include customer relationships of $451 million (20 year weighted-average useful life), technology of $12 million (7 year weighted-average useful life), and $2 million of protective rights in the form of non-compete agreements (5 year weighted-average useful life).

The Company expensed transaction costs of $3.3 million related to the acquisitions as corporate general and administrative expenses, as incurred.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

Inventories

12 Months Ended

Dec. 31, 2015

Inventories [Abstract]

Inventories [Text Block]

(3)	Inventories

The components of inventories at December 31 were as follows (in thousands):

	2015			2014
Raw materials and supplies	$	120,811		$	124,103
Work in process		22,979			29,358
Finished products		80,118			79,184
Inventory reserves		(34,040	)		(38,879	)
	$	189,868		$	193,766

Property, Plant and Equipment

12 Months Ended

Dec. 31, 2015

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment [Text Block]

(4)	Property, Plant and Equipment

The components of property, plant and equipment at December 31 were as follows (in thousands):

	2015			2014
Land	$	2,488		$	4,130
Buildings		79,182			80,775
Machinery and other equipment		319,416			320,697
		401,086			405,602
Accumulated depreciation		(295,576	)		(294,726	)
	$	105,510		$	110,876

Depreciation and amortization expense related to property, plant and equipment was $38,185, $40,890 and $37,756 for the years ended December 31, 2015, 2014 and 2013, respectively.

Goodwill and Other Intangible Assets

12 Months Ended

Dec. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]

(5)	Goodwill and Other Intangible Assets

The carrying value of goodwill by segment was as follows (in thousands):

	Medical & Scientific Imaging			RF Technology			Industrial Technology			Energy Systems & Controls			Total
Balances at December 31, 2013	$	2,435,506		$	1,254,294		$	425,501		$	434,697		$	4,549,998
Goodwill acquired		174,347			33,596			-			-			207,943
Currency translation adjustments		(18,847	)		(7,102	)		(16,537	)		(8,002	)		(50,488	)
Reclassifications and other		3,350			-			-			(112	)		3,238
Balances at December 31, 2014	$	2,594,356		$	1,280,788		$	408,964		$	426,583		$	4,710,691
Goodwill acquired		476,106			720,345			-			-			1,196,451
Goodwill written off related to divestiture of business		-			-			(20,524	)		-			(20,524	)
Currency translation adjustments		(31,556	)		(7,667	)		(14,407	)		(8,386	)		(62,016	)
Reclassifications and other		291			(167	)		-			-			124
Balances at December 31, 2015	$	3,039,197		$	1,993,299		$	374,033		$	418,197		$	5,824,726

Reclassifications and other during the year ended December 31, 2015 were due primarily to tax and intangible adjustments for 2014 acquisitions, and during the year ended December 31, 2014 were due primarily to immaterial out of period corrections of tax adjustments for Sunquest that were not material in the current or prior periods. See Note 2 for information regarding acquisitions and divestitures.

Other intangible assets were comprised of (in thousands):

	Cost		Accum. amort.			Net book value
Assets subject to amortization:
Customer related intangibles	$	1,975,334	$	(543,594	)	$	1,431,740
Unpatented technology		217,260		(134,702	)		82,558
Software		156,449		(62,882	)		93,567
Patents and other protective rights		26,463		(18,325	)		8,138
Backlog		1,100		(443	)		657
Trade names		622		(72	)		550
Assets not subject to amortization:
Trade names		361,519		-			361,519
Balances at December 31, 2014	$	2,738,747	$	(760,018	)	$	1,978,729

Assets subject to amortization:
Customer related intangibles	$	2,448,509	$	(602,615	)	$	1,845,894
Unpatented technology		270,170		(117,405	)		152,765
Software		161,201		(44,298	)		116,903
Patents and other protective rights		24,160		(18,659	)		5,501
Backlog		700		(700	)		-
Trade names		595		(122	)		473
Assets not subject to amortization:
Trade names		407,460		-			407,460
Balances at December 31, 2015	$	3,312,795	$	(783,799	)	$	2,528,996

Amortization expense of other intangible assets was $164 million, $153 million, and $147 million during the years ended December 31, 2015, 2014 and 2013, respectively. Amortization expense is expected to be $188 million in 2016, $178 million in 2017, $170 million in 2018, $162 million in 2019 and $156 million in 2020.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

Accrued Liabilities

12 Months Ended

Dec. 31, 2015

Accrued Liabilities [Abstract]

Accrued Liabilities [Text Block]

(6)	Accrued Liabilities

Accrued liabilities at December 31 were as follows (in thousands):

	2015		2014
Interest	$	19,776	$	18,275
Customer deposits		15,094		16,392
Commissions		12,079		12,025
Warranty		10,183		9,537
Accrued dividend		30,436		25,032
Rebates		16,511		12,968
Billings in excess of cost		5,464		14,135
Other		58,970		52,374
	$	168,513	$	160,738

Income Taxes

12 Months Ended

Dec. 31, 2015

Income Taxes [Abstract]

Income Taxes [Text Block]

(7)	Income Taxes

Earnings before income taxes for the years ended December 31, 2015, 2014 and 2013 consisted of the following components (in thousands):

	2015		2014		2013
United States	$	710,614	$	665,219	$	517,432
Other		291,731		256,237		236,698
	$	1,002,345	$	921,456	$	754,130

Components of income tax expense for the years ended December 31, 2015, 2014 and 2013 were as follows (in thousands):

	2015			2014			2013
Current:
Federal	$	229,224		$	218,302		$	166,430
State		22,041			37,155			12,577
Foreign		71,507			56,107			40,451
Deferred:
Domestic		(10,134	)		(30,664	)		(1,965	)
Foreign		(6,360	)		(5,477	)		(1,656	)
	$	306,278		$	275,423		$	215,837

Reconciliations between the statutory federal income tax rate and the effective income tax rate for the years ended December 31, 2015, 2014 and 2013 were as follows:

	2015			2014			2013
Federal statutory rate		35.0	%		35.0	%		35.0	%
Foreign rate differential		(3.3	)		(3.9	)		(4.1	)
R&D tax credits		(0.5	)		(0.4	)		(0.5	)
State taxes, net of federal benefit		2.0			2.0			1.9
Section 199 deduction		(1.3	)		(1.6	)		(1.8	)
Other, net		(1.3	)		(1.2	)		(1.9	)
		30.6	%		29.9	%		28.6	%

The deferred income tax balance sheet accounts arise from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes.

Components of the deferred tax assets and liabilities at December 31 were as follows (in thousands):

	2015			2014
Deferred tax assets:
Reserves and accrued expenses	$	146,014		$	130,508
Inventories		9,309			10,186
Net operating loss carryforwards		45,616			41,480
R&D credits		8,504			7,145
Foreign tax credits		7,940			-
Valuation allowance		(19,338	)		(16,169	)
Total deferred tax assets	$	198,045		$	173,150
Deferred tax liabilities:
Reserves and accrued expenses	$	11,222		$	27,981
Amortizable intangible assets		962,143			798,502
Plant and equipment		4,004			4,741
Total deferred tax liabilities	$	977,369		$	831,224

At December 31, 2015, the Company had approximately $17.5 million of tax-effected U.S. federal net operating loss carryforwards that if not utilized will expire in years 2023 through 2035. The U.S. federal net operating loss carryforwards increased from 2014 to 2015 primarily due to to additional net operating losses obtained through a recent acquisition. In a recent acquisition, the consolidated group obtained U.S. federal net operating losses subject to an IRC Section 382 limitation; however, the Company expects to utilize the losses in their entirety prior to expiration. The Company has approximately $22.9 million of tax-effected state net operating loss carryforwards (without regard to federal benefit of state) that if not utilized will expire in years 2016 through 2035. The state net operating loss carryforwards are primarily related to Florida, Georgia and New Jersey, but the Company has smaller net operating losses in various other states. The Company has approximately $13.1 million of tax-effected foreign net operating loss carryforwards that if not utilized will begin to expire in 2016, while some do not have a definite expiration. Additionally, the Company has $12.4 million of U.S. federal and state research and development tax credit carryforwards (without regard to federal benefit of state) that will expire in years 2019 through 2035 and $7.9 million of U.S. federal foreign tax credits that, if not utilized, will expire in 2025.

As of December 31, 2015, the Company determined that a total valuation allowance of $19.3 million was necessary to reduce U.S. deferred tax assets by $11.0 million and foreign deferred tax assets by $8.3 million, where it was more likely than not that some portion or all of such deferred tax assets will not be realized. As of December 31, 2015, based on the Company's estimates of future taxable income and any applicable tax-planning strategies within various tax jurisdictions, the Company believes that it is more likely than not that the remaining net deferred tax assets will be realized.

The Company recognizes in the consolidated financial statements only those tax positions determined to be "more likely than not" of being sustained upon examination based on the technical merits of the positions. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):

	2015			2014			2013
Beginning balance	$	28,567		$	26,924		$	24,865
Additions for tax positions of prior periods		3,525			6,532			3,055
Additions for tax positions of the current period		3,299			5,571			1,639
Additions due to acquisitions		6,177			-			5,026
Reductions for tax positions of prior periods		(12,206	)		(1,008	)		(3,675	)
Reductions for tax positions of the current period
Settlements with taxing authorities		(142	)		(518	)		-
Lapse of applicable statute of limitations		(3,080	)		(8,934	)		(3,986	)
Ending balance	$	26,140		$	28,567		$	26,924

The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate is $24.2 million. Interest and penalties related to unrecognized tax benefits are classified as a component of income tax expense and totaled a benefit of $1.8 million in 2015. Accrued interest and penalties were $3.4 million at December 31, 2015 and $5.2 million at December 31, 2014. During the next twelve months, the unrecognized tax benefits are expected to decrease by a net $3.2 million, due mainly to anticipated statute of limitations lapses in various jurisdictions.

The Company and its subsidiaries are subject to U.S. federal income tax as well as income taxes of multiple state, city and foreign jurisdictions. The Company's federal income tax returns for 2013 through the current period remain subject to examination and the relevant state, city and foreign statutes vary. At December 31, 2015, the Internal Revenue Service has been and is continuing to examine the Company's income tax returns for the years 2013 and 2014. The Company does not expect the assessment of any significant additional tax in excess of amounts reserved.

Long-Term Debt

12 Months Ended

Dec. 31, 2015

Long-Term Debt [Abstract]

Long-Term Debt [Text Block]

(8)	Long-Term Debt

On July 27, 2012, Roper entered into a $1.5 billion unsecured credit facility (the "2012 Facility") with JPMorgan Chase Bank, N.A., as administrative agent, and a syndicate of lenders. The 2012 Facility included a provision which allowed Roper, subject to compliance with specified conditions, to request term loans or additional revolving credit commitments in an aggregate amount not to exceed $350 million. On October 28, 2015, Roper increased its revolving credit capacity by $350 million, bringing the total revolving credit facility to $1.85 billion. At December 31, 2015, there were $180 million of outstanding borrowings under the 2012 Facility.

The 2012 Facility contains affirmative and negative covenants which, among other things, limit Roper's ability to incur new debt, prepay subordinated debt, make certain investments and acquisitions, sell assets and grant liens, make restricted payments (including the payment of dividends on our common stock) and capital expenditures, or change its line of business. Roper is also subject to financial covenants which require the Company to limit its consolidated total leverage ratio and to maintain a consolidated interest coverage ratio. The most restrictive covenant is the consolidated total leverage ratio which is limited to 3.5.

The Company was in compliance with its debt covenants throughout the years ended December 31, 2015 and 2014.

On December 7, 2015, the Company completed a public offering of $600 million aggregate principal amount of 3.00% senior unsecured notes due December 15, 2020 and $300 million aggregate principal amount of 3.85% senior unsecured notes due December 15, 2025. The notes bear interest at a fixed rate of 3.00% and 3.85% per year, respectively, payable semi-annually in arrears on June 15 and December 15 of each year, beginning June 15, 2016.

On June 6, 2013, the Company completed a public offering of $800 million aggregate principal amount of 2.05% senior unsecured notes due October 1, 2018. The notes bear interest at a fixed rate of 2.05% per year, payable semi-annually in arrears on April 1 and October 1 of each year, beginning October 1, 2013.

On November 21, 2012, Roper completed a public offering of $400 million aggregate principal amount of 1.85% senior unsecured notes due November 15, 2017 and $500 million aggregate principal amount of 3.125% senior unsecured notes due November 15, 2022. The notes bear interest at a fixed rate of 1.85% and 3.125% per year, respectively, payable semi-annually in arrears on May 15 and November 15 of each year, beginning May 15, 2013.

In September 2009, the Company completed a public offering of $500 million aggregate principal amount of 6.25% senior unsecured notes due September 1, 2019. The notes bear interest at a fixed rate of 6.25% per year, payable semi-annually in arrears on March 1 and September 1 of each year, beginning March 1, 2010.

Roper may redeem some or all of these notes at any time or from time to time, at 100% of their principal amount, plus a make-whole premium based on a spread to U.S. Treasury securities.

The Company's senior notes are unsecured senior obligations of the Company and rank equally in right of payment with all of Roper's existing and future unsecured and unsubordinated indebtedness. The notes are effectively subordinated to any of its existing and future secured indebtedness to the extent of the value of the collateral securing such indebtedness. The notes are not guaranteed by any of Roper's subsidiaries and are effectively subordinated to all existing and future indebtedness and other liabilities of Roper's subsidiaries.

Other debt includes $4 million of senior subordinated convertible notes due December 31, 2034.

Total debt at December 31 consisted of the following (in thousands):

	2015			2014
$1.85 billion revolving credit facility	$	180,000		$	-
2017 Notes		400,000			400,000
2018 Notes		800,000			800,000
2019 Notes		500,000			500,000
2020 Notes		600,000			-
2022 Notes		500,000			500,000
2025 Notes		300,000			-
Senior Subordinated Convertible Notes		4,179			8,003
Other		4,435			6,120
Less unamortized debt issuance costs		(17,392	)		(12,749	)
Total debt		3,271,222			2,201,374
Less current portion		6,805			11,092
Long-term debt	$	3,264,417		$	2,190,282

As disclosed in Note 1, the Company early adopted the ASU issued in April 2015 requiring the Company to present debt issuance costs related to the senior notes as a direct deduction from the principal amount on the consolidated balance sheets. The update required retrospective adoption, and the 2014 consolidated balance sheet has been adjusted by reducing both Other assets (long-term) and Long-term debt, net of current portion by $13 million, the amount of unamortized debt issuance costs related to Roper's senior notes at December 31, 2014.

The 2012 Facility and Roper's $3.1 billion senior notes provide substantially all of Roper's daily external financing requirements. The interest rate on the borrowings under the 2012 Facility is calculated based upon various recognized indices plus a margin as defined in the credit agreement. At December 31, 2015, Roper's debt consisted of $3.1 billion of senior notes and $4 million of senior subordinated convertible notes. In addition, the Company had $4 million of other debt in the form of capital leases, several smaller facilities that allow for borrowings or the issuance of letters of credit in foreign locations to support Roper's non-U.S. businesses and $43 million of outstanding letters of credit at December 31, 2015.

In December 2003, the Company issued through a public offering $230 million of 3.75% subordinated convertible notes due in 2034 at an original issue discount of 60.498% (the "Convertible Notes"). The Convertible Notes are subordinated in right of payment and collateral to all of Roper's existing and future senior debt. Cash interest on the notes was paid semi-annually until January 15, 2009, after which interest is recognized at the effective rate of 3.75% and represents accrual of original issue discount, and only contingent cash interest may be paid. Contingent cash interest may be paid during any six month period if the average trading price of a note for a five trading day measurement period preceding the applicable six month period equals 120% or more of the sum of the issue price, accrued original issue discount and accrued cash interest, if any, for such note. The contingent cash interest payable per note in respect of any six month period will equal the annual rate of 0.25%. In accordance with this criterion, contingent interest has been paid for each six month period since January 15, 2009. Holders receive cash up to the value of the accreted principal amount of the notes converted and, at the Company's option, any remainder of the conversion value may be paid in cash or shares of common stock. Holders may require Roper to purchase all or a portion of their notes on January 15, 2019 at a price of $572.76 per note, on January 15, 2024 at a price of $689.68 per note, and on January 15, 2029 at a price of $830.47 per note, in each case plus accrued cash interest, if any, and accrued contingent cash interest, if any. The Company may only pay the purchase price of such notes in cash and not in common stock. In addition, if Roper experiences a change in control, each holder may require Roper to purchase for cash all or a portion of such holder's notes at a price equal to the sum of the issue price plus accrued original issue discount for non-tax purposes, accrued cash interest, if any, and accrued contingent cash interest, if any, to the date of purchase.

The Convertible Notes are classified as short-term debt as the notes became convertible on October 1, 2005 based upon the Company's common stock trading above the trigger price for at least 20 trading days during the 30 consecutive trading-day periods ending on September 30, 2005.

At December 31, 2015, the conversion price on the outstanding Convertible Notes was $511.62. If converted at December 31, 2015, the value would have exceeded the $4 million principal amount of the Convertible Notes by $16 million and could have resulted in the issuance of 81,778 shares of the Company's common stock.

Future maturities of total debt during each of the next five years ending December 31 and thereafter were as follows (in thousands):

2016	$	6,805
2017		581,296
2018		800,460
2019		500,053
2020		600,000
Thereafter		800,000
Total	$	3,288,614

Fair Value

12 Months Ended

Dec. 31, 2015

Fair Value [Abstract]

Fair Value of Financial Instruments

(9)	Fair Value

Roper's debt at December 31, 2015 included $3.1 billion of fixed-rate senior notes with the following fair values (in millions):

$400 million 2017 Notes	$	398
$800 million 2018 Notes		795
$500 million 2019 Notes		553
$600 million 2020 Notes		599
$500 million 2022 Notes		488
$300 million 2025 Notes		304

The fair values of the senior notes are based on the trading prices of the notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy. Short-term debt included $4 million of fixed-rate convertible notes which were at fair value due to the short-term nature of the notes. Most of Roper's other borrowings at December 31, 2015 were at various interest rates that adjust relatively frequently under its credit facility. The fair value for each of these borrowings at December 31, 2015 was estimated to be the face value of these borrowings.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Retirement and Other Benefit Plans

12 Months Ended

Dec. 31, 2015

Retirement and Other Benefit Plans [Abstract]

Retirement and Other Benefit Plans [Text Block]

(10)	Retirement and Other Benefit Plans

Roper maintains four defined contribution retirement plans under the provisions of Section 401(k) of the IRC covering substantially all U.S. employees not subject to collective bargaining agreements. Roper partially matches employee contributions. Costs related all such plans were $20.4 million, $19.5 million and $16.5 million for 2015, 2014 and 2013, respectively.

Roper also maintains various defined benefit retirement plans covering employees of non-U.S. and certain U.S. subsidiaries and a plan that supplements certain employees for the contribution ceiling applicable to the Section 401(k) plans. The costs and accumulated benefit obligations associated with each of these plans were not material.

Stock-Based Compensation

12 Months Ended

Dec. 31, 2015

Stock-Based Compensation [Abstract]

Stock-Based Compensation [Text Block]

(11)	Stock-Based Compensation

The Roper Technologies, Inc. Amended and Restated 2006 Incentive Plan ("2006 Plan") is a stock-based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to the Company's employees, officers, directors and consultants. The 2006 Plan replaced the Amended and Restated 2000 Incentive Plan ("2000 Plan"), and no additional grants will be made from the 2000 Plan. The number of shares reserved for issuance under the 2006 Plan is 14,000,000, plus 17,000 remaining shares that were available to grant under the 2000 Plan at June 28, 2006, plus any shares underlying outstanding awards under the 2000 Plan that terminate or expire unexercised, or are cancelled, forfeited or lapse for any reason subsequent to June 28, 2006. At December 31, 2015, 3,175,605 shares were available to grant.

Under the Roper Technologies, Inc., Employee Stock Purchase Plan ("ESPP"), all employees in the U.S. and Canada are eligible to designate up to 10% of eligible earnings to purchase Roper's common stock at a 5% discount to the average closing price of its common stock at the beginning and end of a quarterly offering period. Common stock sold to the employees may be either treasury stock, stock purchased on the open market, or newly issued shares.

Stock based compensation expense for the years ended December 31, 2015, 2014 and 2013 was as follows (in millions):

	2015		2014		2013
Stock based compensation	$	61.8	$	63.0	$	53.4
Tax benefit recognized in net income		21.6		22.1		18.7
Windfall tax benefit, net		22.2		21.5		16.0

Stock Options – Stock options are typically granted at prices not less than 100% of market value of the underlying stock at the date of grant. Stock options typically vest over a period of three to five years from the grant date and expire ten years after the grant date. The Company recorded $15.3 million, $16.6 million, and $16.9 million of compensation expense relating to outstanding options during 2015, 2014 and 2013, respectively, as a component of general and administrative expenses, primarily at corporate.

The Company estimates the fair value of its option awards using the Black-Scholes option valuation model. The stock volatility for each grant is measured using the weighted-average of historical daily price changes of the Company's common stock over the most recent period equal to the expected life of the grant. The expected term of options granted is derived from historical data to estimate option exercises and employee forfeitures, and represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The weighted-average fair value of options granted in 2015, 2014 and 2013 were calculated using the following weighted-average assumptions:

	2015		2014		2013
Weighted-average fair value ($)		33.98		34.95		37.08
Risk-free interest rate (%)		1.53		1.63		0.86
Average expected option life (years)		5.10		5.22		5.19
Expected volatility (%)		22.17		27.01		36.09
Expected dividend yield (%)		0.62		0.58		0.56

The following table summarizes the Company's activities with respect to its stock option plans for the years ended December 31, 2015 and 2014:

	Number of shares			Weighted-average exercise price per share		Weighted-average contractual term		Aggregate intrinsic value
Outstanding at January 1, 2014		2,988,436		$	74.00
Granted		650,000			137.05
Exercised		(587,661	)		55.98
Canceled		(69,664	)		116.29
Outstanding at December 31, 2014		2,981,111			90.48		6.37		$	196,378,239
Granted		628,155			162.77
Exercised		(400,050	)		82.50
Canceled		(91,600	)		142.36
Outstanding at December 31, 2015		3,117,616			104.54		6.08		$	265,782,636
Exercisable at December 31, 2015		1,935,351		$	78.76		4.55		$	214,879,670

The following table summarizes information for stock options outstanding at December 31, 2015:

		Outstanding options						Exercisable options
Exercise price		Number		Average exercise price		Average remaining life (years)		Number		Average exercise price
$	38.46 - 57.68		896,590	$	53.04		2.4		896,590	$	53.04
	57.69 - 76.91		298,733		72.65		5.1		298,733		72.65
	76.92 - 96.14		295,684		93.16		6.1		294,434		93.15
	96.15 - 115.37		310,597		114.82		7.0		200,319		114.60
	115.38 - 134.60		562,626		130.96		8.0		195,520		130.52
	134.61- 153.82		272,036		144.28		8.7		37,422		142.12
	153.83 - 173.05		413,350		165.00		9.2		11,000		156.57
	173.06 - 192.28		68,000		181.14		9.7		1,333		175.00
$	38.46 - 192.28		3,117,616	$	104.54		6.1		1,935,351	$	78.76

At December 31, 2015, there was $26.5 million of total unrecognized compensation expense related to nonvested options granted under the Company's share-based payment plans. That cost is expected to be recognized over a weighted-average period of 1.9 years. The total intrinsic value of options exercised in 2015, 2014 and 2013 was $36.9 million, $50.3 million and $28.8 million, respectively. Cash received from option exercises under all plans in 2015 and 2014 was $33.0 million and $32.5 million, respectively.

Restricted Stock Grants - During 2015 and 2014, the Company granted 437,035 and 375,060 shares, respectively, of restricted stock to certain employee and director participants under the 2006 Plan. Restricted stock grants generally vest over a period of 1 to 3 years. The Company recorded $46.5 million, $46.4 million and $36.5 million of compensation expense related to outstanding shares of restricted stock held by employees and directors during 2015, 2014 and 2013, respectively. A summary of the Company's nonvested shares activity for 2015 and 2014 is as follows:

	Number of shares			Weighted-average grant date fair value
Nonvested at December 31, 2013		573,850		$	103.44
Granted		375,060			142.30
Vested		(378,994	)		153.16
Forfeited		(27,361	)		106.60
Nonvested at December 31, 2014		542,555		$	130.29
Granted		437,035			159.32
Vested		(243,423	)		183.10
Forfeited		(26,892	)		148.82
Nonvested at December 31, 2015		709,275		$	183.90

At December 31, 2015, there was $62.2 million of total unrecognized compensation expense related to nonvested awards granted to both employees and directors under the Company's share-based payment plans. That cost is expected to be recognized over a weighted-average period of 2.4 years. Unrecognized compensation expense related to nonvested shares of restricted stock grants is recorded as a reduction to additional paid-in capital in stockholder's equity at December 31, 2015.

Employee Stock Purchase Plan - During 2015, 2014 and 2013, participants of the ESPP purchased 18,132, 20,368 and 20,211 shares, respectively, of Roper's common stock for total consideration of $2.9 million, $2.8 million, and $2.4 million, respectively. All of these shares were purchased from Roper's treasury shares. The Company had no compensation expense relating to the stock purchase plan during 2015, 2014 and 2013.

Contingencies

12 Months Ended

Dec. 31, 2015

Contingencies [Abstract]

Contingencies [Text Block]

(12)	Contingencies

Roper, in the ordinary course of business, is the subject of, or a party to, various pending or threatened legal actions, including product liability and employment practices. It is vigorously contesting all lawsuits that, in general, are based upon claims of the kind that have been customary over the past several years. After analyzing the Company's contingent liabilities on a gross basis and, based upon past experience with resolution of its product liability and employment practices claims and the limits of the primary, excess, and umbrella liability insurance coverages that are available with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance. The ultimate liability, if any, arising from these actions should not have a material adverse effect on the consolidated financial position, results of operations or cash flows of Roper.

Roper or its subsidiaries have been named defendants along with numerous industrial companies in asbestos-related litigation claims in certain U.S. states. No significant resources have been required by Roper to respond to these cases and Roper believes it has valid defenses to such claims and, if required, intends to defend them vigorously. Given the state of these claims it is not possible to determine the potential liability, if any.

Roper's rent expense was $40.2 million, $38.4 million and $39.8 million for 2015, 2014 and 2013, respectively. Roper's future minimum property lease commitments are as follows (in millions):

2016	$	36.7
2017		31.1
2018		20.6
2019		14.3
2020		11.6
Thereafter		32.5
Total	$	146.8

A summary of the Company's warranty accrual activity is presented below (in thousands):

	2015			2014			2013
Balance, beginning of year	$	9,537		$	14,336		$	9,755
Additions charged to costs and expenses		14,284			13,396			20,387
Deductions		(13,059	)		(18,078	)		(15,697	)
Other		(579	)		(117	)		(109	)
Balance, end of year	$	10,183		$	9,537		$	14,336

Other included warranty balances at acquired businesses at the dates of acquisition, the effects of foreign currency translation adjustments, reclassifications and other.

As of December 31, 2015, Roper had $43 million of letters of credit issued to guarantee its performance under certain services contracts or to support certain insurance programs and $505 million of outstanding surety bonds. Certain contracts, primarily those involving public sector customers, require Roper to provide a surety bond as a guarantee of its performance of contractual obligations.

Segment and Geographic Area Information

12 Months Ended

Dec. 31, 2015

Business Segments [Abstract]

Business Segments [Text Block]

(13)	Segment and Geographic Area Information

Roper's operations are reported in four segments around common customers, markets, sales channels, technologies and common cost opportunities. The segments are: Medical & Scientific Imaging, RF Technology, Industrial Technology and Energy Systems & Controls. The Medical & Scientific Imaging segment offers medical products and software, high performance digital imaging products and software. The RF Technology segment includes products and systems related to comprehensive toll and traffic systems and processing, security and access control, campus card systems, card readers, software-as-a-service applications in the freight matching and food industries, comprehensive business software for legal and construction firms and utility metering and remote monitoring applications. Products included within the Industrial Technology segment are water and fluid handling pumps, flow measurement and metering equipment, industrial valves and controls, materials analysis equipment and consumables and industrial leak testing. The Energy Systems & Controls segment's products include control systems, equipment and consumables for fluid properties testing, vibration sensors and other non-destructive inspection and measurement products and services. Roper's management structure and internal reporting are aligned consistently with these four segments.

There were no material transactions between Roper's business segments during 2015, 2014 and 2013. Sales between geographic areas are primarily of finished products and are accounted for at prices intended to represent third-party prices. Operating profit by business segment and by geographic area is defined as net sales less operating costs and expenses. These costs and expenses do not include unallocated corporate administrative expenses. Items below income from operations on Roper's statement of earnings are not allocated to business segments.

Identifiable assets are those assets used primarily in the operations of each business segment or geographic area. Corporate assets are principally comprised of cash and cash equivalents, deferred tax assets, recoverable insurance claims, deferred compensation assets and property and equipment.

Selected financial information by business segment for 2015, 2014 and 2013 follows (in thousands):

	Medical & Scientific Imaging		RF Technology		Industrial Technology		Energy Systems & Controls		Corporate			Total
2015
Net sales	$	1,215,318	$	1,033,951	$	745,381	$	587,745	$	-		$	3,582,395
Operating profit		441,931		312,112		214,538		162,128		(102,791	)		1,027,918
Assets:
Operating assets		265,520		293,004		182,544		194,898		9,080			945,046
Intangible assets, net		4,451,028		2,848,911		513,155		540,628		-			8,353,722
Other		121,461		117,596		67,832		113,014		449,694			869,597
Total													10,168,365
Capital expenditures		12,642		10,758		9,179		3,276		405			36,260
Depreciation and other amortization		105,928		56,877		19,912		21,254		290			204,261
2014
Net sales	$	1,080,309	$	950,227	$	827,145	$	691,813	$	-		$	3,549,494
Operating profit		375,867		271,177		247,596		203,021		(98,188	)		999,473
Assets:
Operating assets		232,380		270,458		220,115		219,284		7,002			949,239
Intangible assets, net		3,842,180		1,720,977		557,593		568,670		-			6,689,420
Other*		147,529		65,636		120,681		223,831		203,849			761,526
Total													8,400,185
Capital expenditures		11,430		10,521		10,713		4,634		346			37,644
Depreciation and other amortization		93,683		58,702		21,135		23,281		483			197,284
2013
Net sales	$	902,281	$	904,363	$	779,564	$	651,920	$	-		$	3,238,128
Operating profit		268,172		253,532		223,053		183,679		(86,075	)		842,361
Assets:
Operating assets		237,681		266,026		232,505		214,926		15,325			966,463
Intangible assets, net		3,682,465		1,725,597		583,822		597,250		-			6,589,134
Other*		152,211		62,576		75,215		167,879		155,642			613,523
Total*													8,169,120
Capital expenditures		10,231		10,190		17,043		4,952		112			42,528
Depreciation and other amortization		85,177		60,590		21,551		21,353		519			189,190

*Other assets have been adjusted due to the adoption of a recent ASU regarding presentation of debt issuance costs (see Note 1). These adjustments were $12,749 and $15,861 for the years ended December 31, 2014 and 2013, respectively.

Summarized data for Roper's U.S. and foreign operations (principally in Canada, Europe and Asia) for 2015, 2014 and 2013, based upon the country of origin of the Roper entity making the sale, was as follows (in thousands):

	United States		Non-U.S.		Eliminations			Total
2015
Sales to unaffiliated customers	$	2,829,752	$	752,643	$	-		$	3,582,395
Sales between geographic areas		135,363		119,006		(254,369	)		-
Net sales	$	2,965,115	$	871,649	$	(254,369	)	$	3,582,395
Long-lived assets	$	133,522	$	21,960	$	-		$	155,482
2014
Sales to unaffiliated customers	$	2,661,470	$	888,024	$	-		$	3,549,494
Sales between geographic areas		159,049		119,175		(278,224	)		-
Net sales	$	2,820,519	$	1,007,199	$	(278,224	)	$	3,549,494
Long-lived assets	$	134,855	$	30,781	$	-		$	165,636
2013
Sales to unaffiliated customers	$	2,400,592	$	837,536	$	-		$	3,238,128
Sales between geographic areas		141,529		121,431		(262,960	)		-
Net sales	$	2,542,121	$	958,967	$	(262,960	)	$	3,238,128
Long-lived assets	$	135,157	$	36,266	$	-		$	171,423

Export sales from the U.S. during the years ended December 31, 2015, 2014 and 2013 were $481 million, $477 million and $479 million, respectively. In the year ended December 31, 2015, these exports were shipped primarily to Asia (36%), Europe (17%), Canada (15%), Middle East (18%), South America (5%), South Pacific (3%) and other (6%).

Sales to customers outside the U.S. accounted for a significant portion of Roper's revenues. Sales are attributed to geographic areas based upon the location where the product is ultimately shipped. Roper's net sales for the years ended December 31, 2015, 2014 and 2013 are shown below by region, except for Canada, which is presented separately as it is the only country in which Roper has had greater than 5% of total sales for any of the three years presented (in thousands):

	Medical & Scientific Imaging		RF Technology		Industrial Technology		Energy Systems & Controls		Total
2015
Canada	$	23,737	$	45,506	$	65,826	$	23,883	$	158,952
Europe		167,698		57,581		97,938		129,021		452,238
Asia		112,732		10,019		60,817		132,088		315,656
Middle East		15,877		54,165		4,220		50,227		124,489
Rest of the world		20,417		10,761		24,471		55,074		110,723
Total	$	340,461	$	178,032	$	253,272	$	390,293	$	1,162,058
2014
Canada	$	24,997	$	45,811	$	106,598	$	31,831	$	209,237
Europe		185,263		54,330		121,909		157,391		518,893
Asia		107,695		7,555		61,552		143,524		320,326
Middle East		9,997		34,241		3,824		42,988		91,050
Rest of the world		28,722		9,333		26,134		78,186		142,375
Total	$	356,674	$	151,270	$	320,017	$	453,920	$	1,281,881

2013
Canada	$	25,502	$	45,954	$	109,361	$	34,260	$	215,077
Europe		168,394		62,825		108,644		153,807		493,670
Asia		103,931		8,134		65,622		136,934		314,621
Middle East		9,361		44,341		3,865		32,444		90,011
Rest of the world		17,856		11,865		26,716		82,956		139,393
Total	$	325,044	$	173,119	$	314,208	$	440,401	$	1,252,772

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

Concentration of Risk

12 Months Ended

Dec. 31, 2015

Concentration of Risk [Abstract]

Concentration of Risk [Text Block]

(14)	Concentration of Risk

Financial instruments which potentially subject the Company to credit risk consist primarily of cash, cash equivalents and trade receivables.

The Company maintains cash and cash equivalents with various major financial institutions around the world. Cash equivalents include investments in commercial paper of companies with high credit ratings, investments in money market securities and securities backed by the U.S. Government. The Company limits the amount of credit exposure with any one financial institution and believes that no significant concentration of credit risk exists with respect to cash investments.

Trade receivables subject the Company to the potential for credit risk with customers. To reduce credit risk, the Company performs ongoing evaluations of its customers' financial condition.

Quarterly Financial Data

12 Months Ended

Dec. 31, 2015

Quarterly Financial Data [Abstract]

Quarterly Financial Data

(15)	Quarterly Financial Data (unaudited)

	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
	(in thousands, except per share data)
2015
Net sales	$	865,281	$	889,541	$	883,933	$	943,640
Gross profit		518,161		533,911		533,483		579,091
Income from operations		246,896		251,974		250,371		278,677
Net earnings		155,773		171,280		160,417		208,597

Earnings from continuing operations per common share:
Basic		1.55		1.70		1.59		2.07
Diluted		1.54		1.69		1.58		2.05

2014
Net sales	$	834,052	$	885,175	$	884,122	$	946,145
Gross profit		488,936		523,182		524,040		565,741
Income from operations		223,400		246,666		245,658		283,749
Net earnings		147,226		157,361		155,510		185,936

Earnings from continuing operations per common share:
Basic		1.48		1.58		1.55		1.86
Diluted		1.46		1.56		1.54		1.84

The sum of the four quarters may not agree with the total for the year due to rounding.

Subsequent Events

12 Months Ended

Dec. 31, 2015

Subsequent Events [Abstract]

Subsequent Events [Text Block]

(16)	Subsequent Event

In the period following December 31, 2015 but before the filing date of this Annual Report, Roper acquired CliniSys Group Ltd. ("CliniSys"), a provider of medical laboratory software headquartered in the United Kingdom for £170 million in cash. Roper purchased CliniSys to expand upon existing medical software platforms. Purchase accounting has not been completed as of the filing date, and no supplemental pro forma data has been provided as the acquisition is immaterial.

Schedule II - Consolidated Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2015

Consolidated Valuation and Qualifying Accounts [Abstract]

Valuation and qualifying accounts

ROPER TECHNOLOGIES, INC. AND SUBSIDIARIES

Schedule II – Consolidated Valuation and Qualifying Accounts

Years ended December 31, 2015, 2014 and 2013

	Balance at beginning of year		Additions charged to costs and expenses		Deductions			Other			Balance at end of year
	(in thousands)
Allowance for doubtful accounts and sales allowances
2015	$	13,694	$	1,536	$	(4,128	)	$	1,302		$	12,404
2014		14,992		2,357		(3,355	)		(300	)		13,694
2013		15,976		1,350		(2,992	)		658			14,992
Reserve for inventory obsolescence
2015	$	38,879	$	8,616	$	(9,049	)	$	(4,406	)	$	34,040
2014		43,452		8,621		(11,833	)		(1,361	)		38,879
2013		41,967		11,360		(9,696	)		(179	)		43,452

Deductions from the allowance for doubtful accounts represented the net write-off of uncollectible accounts receivable. Deductions from the inventory obsolescence reserve represented the disposal of obsolete items.

Other included the allowance for doubtful accounts and reserve for inventory obsolescence of acquired businesses at the dates of acquisition, the effects of foreign currency translation adjustments for those companies whose functional currency was not the U.S. dollar, reclassifications and other.

Summary of Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2015

Summary of Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation - Effective April 24, 2015, Roper Industries, Inc. changed its name to Roper Technologies, Inc. in order to reflect its continued evolution to a diversified technology company.

Nature of the Business

Accounts Receivable

Cash and Cash Equivalents

Contingencies

Earnings per Share

	Years ended December 31,
	2015		2014		2013
Basic weighted-average shares outstanding		100,616		99,916		99,123
Effect of potential common stock:
Common stock awards		887		816		891
Senior subordinated convertible notes		94		152		195
Diluted weighted-average shares outstanding		101,597		100,884		100,209

Estimates

Foreign Currency Translation

Goodwill and Other Intangibles

The following events or circumstances, although not comprehensive, would be considered to determine whether interim testing of goodwill would be required:

●

a significant adverse change in legal factors or in the business climate;

●

an adverse action or assessment by a regulator;

●

unanticipated competition;

●

a loss of key personnel;

●

a more-likely-than-not expectation that a reporting unit or a significant portion of a reporting unit will be sold or otherwise disposed of;

●

the testing for recoverability under the Impairment or Disposal of Long-Lived Assets of a significant asset group within a reporting unit; and

●

recognition of a goodwill impairment loss in the financial statements of a subsidiary that is a component of a reporting unit.

Impairment of Long-Lived Assets

Income Taxes

Interest Rate Risk

Inventories

Other Comprehensive Earnings

Other Comprehensive Income - Comprehensive income includes net earnings and all other non-owner sources of changes in a company's net assets.

Property, Plant and Equipment and Depreciation and Amortization

Buildings	20-30 years
Machinery	8-12 years
Other equipment	3-5 years

Recently Released Accounting Pronouncements

Research and Development Disclosure [Text Block]

Revenue Recognition

Revenue Recognition - The Company recognizes revenue when all of the following criteria are met:

●

persuasive evidence of an arrangement exists;

●

delivery has occurred or services have been rendered;

●

the seller's price to the buyer is fixed or determinable; and

●

collectibility is reasonably assured.

Capitalized Software

Stock-Based Compensation

Summary of Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2015

Summary of Accounting Policies [Abstract]

Schedule of Weighted Average Diluted Shares Outstanding Table

	Years ended December 31,
	2015		2014		2013
Basic weighted-average shares outstanding		100,616		99,916		99,123
Effect of potential common stock:
Common stock awards		887		816		891
Senior subordinated convertible notes		94		152		195
Diluted weighted-average shares outstanding		101,597		100,884		100,209

Property, plant and equipment table

Buildings	20-30 years
Machinery	8-12 years
Other equipment	3-5 years

The components of property, plant and equipment at December 31 were as follows (in thousands):

	2015			2014
Land	$	2,488		$	4,130
Buildings		79,182			80,775
Machinery and other equipment		319,416			320,697
		401,086			405,602
Accumulated depreciation		(295,576	)		(294,726	)
	$	105,510		$	110,876

Business Acquisitions (Tables)

12 Months Ended

Dec. 31, 2015

Business Acquisitions [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table (in thousands) summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition.

Current assets	$	59,813
Identifiable intangibles		465,500
Goodwill		678,183
Other assets		5,798
Total assets acquired		1,209,294
Current liabilities		(24,717	)
Long-term deferred tax liability		(162,503	)
Other liabilities		(6,524	)
Net assets acquired	$	1,015,550

Inventories (Tables)

12 Months Ended

Dec. 31, 2015

Inventories [Abstract]

Inventories

The components of inventories at December 31 were as follows (in thousands):

	2015			2014
Raw materials and supplies	$	120,811		$	124,103
Work in process		22,979			29,358
Finished products		80,118			79,184
Inventory reserves		(34,040	)		(38,879	)
	$	189,868		$	193,766

Property, Plant and Equipment (Tables)

12 Months Ended

Dec. 31, 2015

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment Table

Buildings	20-30 years
Machinery	8-12 years
Other equipment	3-5 years

The components of property, plant and equipment at December 31 were as follows (in thousands):

	2015			2014
Land	$	2,488		$	4,130
Buildings		79,182			80,775
Machinery and other equipment		319,416			320,697
		401,086			405,602
Accumulated depreciation		(295,576	)		(294,726	)
	$	105,510		$	110,876

Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

The carrying value of goodwill by segment was as follows (in thousands):

	Medical & Scientific Imaging			RF Technology			Industrial Technology			Energy Systems & Controls			Total
Balances at December 31, 2013	$	2,435,506		$	1,254,294		$	425,501		$	434,697		$	4,549,998
Goodwill acquired		174,347			33,596			-			-			207,943
Currency translation adjustments		(18,847	)		(7,102	)		(16,537	)		(8,002	)		(50,488	)
Reclassifications and other		3,350			-			-			(112	)		3,238
Balances at December 31, 2014	$	2,594,356		$	1,280,788		$	408,964		$	426,583		$	4,710,691
Goodwill acquired		476,106			720,345			-			-			1,196,451
Goodwill written off related to divestiture of business		-			-			(20,524	)		-			(20,524	)
Currency translation adjustments		(31,556	)		(7,667	)		(14,407	)		(8,386	)		(62,016	)
Reclassifications and other		291			(167	)		-			-			124
Balances at December 31, 2015	$	3,039,197		$	1,993,299		$	374,033		$	418,197		$	5,824,726

Other Intangible Assets

Other intangible assets were comprised of (in thousands):

	Cost		Accum. amort.			Net book value
Assets subject to amortization:
Customer related intangibles	$	1,975,334	$	(543,594	)	$	1,431,740
Unpatented technology		217,260		(134,702	)		82,558
Software		156,449		(62,882	)		93,567
Patents and other protective rights		26,463		(18,325	)		8,138
Backlog		1,100		(443	)		657
Trade names		622		(72	)		550
Assets not subject to amortization:
Trade names		361,519		-			361,519
Balances at December 31, 2014	$	2,738,747	$	(760,018	)	$	1,978,729

Assets subject to amortization:
Customer related intangibles	$	2,448,509	$	(602,615	)	$	1,845,894
Unpatented technology		270,170		(117,405	)		152,765
Software		161,201		(44,298	)		116,903
Patents and other protective rights		24,160		(18,659	)		5,501
Backlog		700		(700	)		-
Trade names		595		(122	)		473
Assets not subject to amortization:
Trade names		407,460		-			407,460
Balances at December 31, 2015	$	3,312,795	$	(783,799	)	$	2,528,996

Accrued Liabilities (Tables)

12 Months Ended

Dec. 31, 2015

Accrued Liabilities [Abstract]

Accrued Liabilities

Accrued liabilities at December 31 were as follows (in thousands):

	2015		2014
Interest	$	19,776	$	18,275
Customer deposits		15,094		16,392
Commissions		12,079		12,025
Warranty		10,183		9,537
Accrued dividend		30,436		25,032
Rebates		16,511		12,968
Billings in excess of cost		5,464		14,135
Other		58,970		52,374
	$	168,513	$	160,738

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2015

Income Taxes [Abstract]

Earnings Before Income Taxes

Earnings before income taxes for the years ended December 31, 2015, 2014 and 2013 consisted of the following components (in thousands):

	2015		2014		2013
United States	$	710,614	$	665,219	$	517,432
Other		291,731		256,237		236,698
	$	1,002,345	$	921,456	$	754,130

Schedule of Components of Income Tax Expense (Benefit)

Components of income tax expense for the years ended December 31, 2015, 2014 and 2013 were as follows (in thousands):

	2015			2014			2013
Current:
Federal	$	229,224		$	218,302		$	166,430
State		22,041			37,155			12,577
Foreign		71,507			56,107			40,451
Deferred:
Domestic		(10,134	)		(30,664	)		(1,965	)
Foreign		(6,360	)		(5,477	)		(1,656	)
	$	306,278		$	275,423		$	215,837

Schedule of Effective Income Tax Rate Reconciliation

Reconciliations between the statutory federal income tax rate and the effective income tax rate for the years ended December 31, 2015, 2014 and 2013 were as follows:

	2015			2014			2013
Federal statutory rate		35.0	%		35.0	%		35.0	%
Foreign rate differential		(3.3	)		(3.9	)		(4.1	)
R&D tax credits		(0.5	)		(0.4	)		(0.5	)
State taxes, net of federal benefit		2.0			2.0			1.9
Section 199 deduction		(1.3	)		(1.6	)		(1.8	)
Other, net		(1.3	)		(1.2	)		(1.9	)
		30.6	%		29.9	%		28.6	%

Schedule of Deferred Tax Assets and Liabilities

Components of the deferred tax assets and liabilities at December 31 were as follows (in thousands):

	2015			2014
Deferred tax assets:
Reserves and accrued expenses	$	146,014		$	130,508
Inventories		9,309			10,186
Net operating loss carryforwards		45,616			41,480
R&D credits		8,504			7,145
Foreign tax credits		7,940			-
Valuation allowance		(19,338	)		(16,169	)
Total deferred tax assets	$	198,045		$	173,150
Deferred tax liabilities:
Reserves and accrued expenses	$	11,222		$	27,981
Amortizable intangible assets		962,143			798,502
Plant and equipment		4,004			4,741
Total deferred tax liabilities	$	977,369		$	831,224

Schedule of Unrecognized Tax Benefits Roll Forward

The Company recognizes in the consolidated financial statements only those tax positions determined to be "more likely than not" of being sustained upon examination based on the technical merits of the positions. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):

	2015			2014			2013
Beginning balance	$	28,567		$	26,924		$	24,865
Additions for tax positions of prior periods		3,525			6,532			3,055
Additions for tax positions of the current period		3,299			5,571			1,639
Additions due to acquisitions		6,177			-			5,026
Reductions for tax positions of prior periods		(12,206	)		(1,008	)		(3,675	)
Reductions for tax positions of the current period
Settlements with taxing authorities		(142	)		(518	)		-
Lapse of applicable statute of limitations		(3,080	)		(8,934	)		(3,986	)
Ending balance	$	26,140		$	28,567		$	26,924

Long-Term Debt (Tables)

12 Months Ended

Dec. 31, 2015

Long-Term Debt [Abstract]

Long Term Debt

Total debt at December 31 consisted of the following (in thousands):

	2015			2014
$1.85 billion revolving credit facility	$	180,000		$	-
2017 Notes		400,000			400,000
2018 Notes		800,000			800,000
2019 Notes		500,000			500,000
2020 Notes		600,000			-
2022 Notes		500,000			500,000
2025 Notes		300,000			-
Senior Subordinated Convertible Notes		4,179			8,003
Other		4,435			6,120
Less unamortized debt issuance costs		(17,392	)		(12,749	)
Total debt		3,271,222			2,201,374
Less current portion		6,805			11,092
Long-term debt	$	3,264,417		$	2,190,282

Future Maturities of Long Term Debt

Future maturities of total debt during each of the next five years ending December 31 and thereafter were as follows (in thousands):

2016	$	6,805
2017		581,296
2018		800,460
2019		500,053
2020		600,000
Thereafter		800,000
Total	$	3,288,614

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

Fair Value (Tables)

12 Months Ended

Dec. 31, 2015

Fair Value [Abstract]

Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block]

Roper's debt at December 31, 2015 included $3.1 billion of fixed-rate senior notes with the following fair values (in millions):

$400 million 2017 Notes	$	398
$800 million 2018 Notes		795
$500 million 2019 Notes		553
$600 million 2020 Notes		599
$500 million 2022 Notes		488
$300 million 2025 Notes		304

Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2015

Stock-Based Compensation [Abstract]

Stock Based Compensation Expense

Stock based compensation expense for the years ended December 31, 2015, 2014 and 2013 was as follows (in millions):

	2015		2014		2013
Stock based compensation	$	61.8	$	63.0	$	53.4
Tax benefit recognized in net income		21.6		22.1		18.7
Windfall tax benefit, net		22.2		21.5		16.0

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

	2015		2014		2013
Weighted-average fair value ($)		33.98		34.95		37.08
Risk-free interest rate (%)		1.53		1.63		0.86
Average expected option life (years)		5.10		5.22		5.19
Expected volatility (%)		22.17		27.01		36.09
Expected dividend yield (%)		0.62		0.58		0.56

The following table summarizes the Company's activities with respect to its stock option plans for the years ended December 31, 2015 and 2014:

Schedule of Share-based Compensation, Stock Option Activity

	Number of shares			Weighted-average exercise price per share		Weighted-average contractual term		Aggregate intrinsic value
Outstanding at January 1, 2014		2,988,436		$	74.00
Granted		650,000			137.05
Exercised		(587,661	)		55.98
Canceled		(69,664	)		116.29
Outstanding at December 31, 2014		2,981,111			90.48		6.37		$	196,378,239
Granted		628,155			162.77
Exercised		(400,050	)		82.50
Canceled		(91,600	)		142.36
Outstanding at December 31, 2015		3,117,616			104.54		6.08		$	265,782,636
Exercisable at December 31, 2015		1,935,351		$	78.76		4.55		$	214,879,670

Summary of Options Outstanding and Exercisable, by Range of Exercise Prices

The following table summarizes information for stock options outstanding at December 31, 2015:

		Outstanding options						Exercisable options
Exercise price		Number		Average exercise price		Average remaining life (years)		Number		Average exercise price
$	38.46 - 57.68		896,590	$	53.04		2.4		896,590	$	53.04
	57.69 - 76.91		298,733		72.65		5.1		298,733		72.65
	76.92 - 96.14		295,684		93.16		6.1		294,434		93.15
	96.15 - 115.37		310,597		114.82		7.0		200,319		114.60
	115.38 - 134.60		562,626		130.96		8.0		195,520		130.52
	134.61- 153.82		272,036		144.28		8.7		37,422		142.12
	153.83 - 173.05		413,350		165.00		9.2		11,000		156.57
	173.06 - 192.28		68,000		181.14		9.7		1,333		175.00
$	38.46 - 192.28		3,117,616	$	104.54		6.1		1,935,351	$	78.76

Schedule of Nonvested Restricted Stock Awards Activity

	Number of shares			Weighted-average grant date fair value
Nonvested at December 31, 2013		573,850		$	103.44
Granted		375,060			142.30
Vested		(378,994	)		153.16
Forfeited		(27,361	)		106.60
Nonvested at December 31, 2014		542,555		$	130.29
Granted		437,035			159.32
Vested		(243,423	)		183.10
Forfeited		(26,892	)		148.82
Nonvested at December 31, 2015		709,275		$	183.90

Contingencies (Tables)

12 Months Ended

Dec. 31, 2015

Contingencies [Abstract]

Schedule of Rent Expense

Roper's rent expense was $40.2 million, $38.4 million and $39.8 million for 2015, 2014 and 2013, respectively. Roper's future minimum property lease commitments are as follows (in millions):

2016	$	36.7
2017		31.1
2018		20.6
2019		14.3
2020		11.6
Thereafter		32.5
Total	$	146.8

Warranty Accrual Activity

A summary of the Company's warranty accrual activity is presented below (in thousands):

	2015			2014			2013
Balance, beginning of year	$	9,537		$	14,336		$	9,755
Additions charged to costs and expenses		14,284			13,396			20,387
Deductions		(13,059	)		(18,078	)		(15,697	)
Other		(579	)		(117	)		(109	)
Balance, end of year	$	10,183		$	9,537		$	14,336

Segment and Geographic Area Information (Tables)

12 Months Ended

Dec. 31, 2015

Business Segments [Abstract]

Schedule of Segment Reporting Information, by Segment

Selected financial information by business segment for 2015, 2014 and 2013 follows (in thousands):

	Medical & Scientific Imaging		RF Technology		Industrial Technology		Energy Systems & Controls		Corporate			Total
2015
Net sales	$	1,215,318	$	1,033,951	$	745,381	$	587,745	$	-		$	3,582,395
Operating profit		441,931		312,112		214,538		162,128		(102,791	)		1,027,918
Assets:
Operating assets		265,520		293,004		182,544		194,898		9,080			945,046
Intangible assets, net		4,451,028		2,848,911		513,155		540,628		-			8,353,722
Other		121,461		117,596		67,832		113,014		449,694			869,597
Total													10,168,365
Capital expenditures		12,642		10,758		9,179		3,276		405			36,260
Depreciation and other amortization		105,928		56,877		19,912		21,254		290			204,261
2014
Net sales	$	1,080,309	$	950,227	$	827,145	$	691,813	$	-		$	3,549,494
Operating profit		375,867		271,177		247,596		203,021		(98,188	)		999,473
Assets:
Operating assets		232,380		270,458		220,115		219,284		7,002			949,239
Intangible assets, net		3,842,180		1,720,977		557,593		568,670		-			6,689,420
Other*		147,529		65,636		120,681		223,831		203,849			761,526
Total													8,400,185
Capital expenditures		11,430		10,521		10,713		4,634		346			37,644
Depreciation and other amortization		93,683		58,702		21,135		23,281		483			197,284
2013
Net sales	$	902,281	$	904,363	$	779,564	$	651,920	$	-		$	3,238,128
Operating profit		268,172		253,532		223,053		183,679		(86,075	)		842,361
Assets:
Operating assets		237,681		266,026		232,505		214,926		15,325			966,463
Intangible assets, net		3,682,465		1,725,597		583,822		597,250		-			6,589,134
Other*		152,211		62,576		75,215		167,879		155,642			613,523
Total*													8,169,120
Capital expenditures		10,231		10,190		17,043		4,952		112			42,528
Depreciation and other amortization		85,177		60,590		21,551		21,353		519			189,190

Sales and Long-Lived Assets by Country of Origin Table

	United States		Non-U.S.		Eliminations			Total
2015
Sales to unaffiliated customers	$	2,829,752	$	752,643	$	-		$	3,582,395
Sales between geographic areas		135,363		119,006		(254,369	)		-
Net sales	$	2,965,115	$	871,649	$	(254,369	)	$	3,582,395
Long-lived assets	$	133,522	$	21,960	$	-		$	155,482
2014
Sales to unaffiliated customers	$	2,661,470	$	888,024	$	-		$	3,549,494
Sales between geographic areas		159,049		119,175		(278,224	)		-
Net sales	$	2,820,519	$	1,007,199	$	(278,224	)	$	3,549,494
Long-lived assets	$	134,855	$	30,781	$	-		$	165,636
2013
Sales to unaffiliated customers	$	2,400,592	$	837,536	$	-		$	3,238,128
Sales between geographic areas		141,529		121,431		(262,960	)		-
Net sales	$	2,542,121	$	958,967	$	(262,960	)	$	3,238,128
Long-lived assets	$	135,157	$	36,266	$	-		$	171,423

Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area Text Block

	Medical & Scientific Imaging		RF Technology		Industrial Technology		Energy Systems & Controls		Total
2015
Canada	$	23,737	$	45,506	$	65,826	$	23,883	$	158,952
Europe		167,698		57,581		97,938		129,021		452,238
Asia		112,732		10,019		60,817		132,088		315,656
Middle East		15,877		54,165		4,220		50,227		124,489
Rest of the world		20,417		10,761		24,471		55,074		110,723
Total	$	340,461	$	178,032	$	253,272	$	390,293	$	1,162,058
2014
Canada	$	24,997	$	45,811	$	106,598	$	31,831	$	209,237
Europe		185,263		54,330		121,909		157,391		518,893
Asia		107,695		7,555		61,552		143,524		320,326
Middle East		9,997		34,241		3,824		42,988		91,050
Rest of the world		28,722		9,333		26,134		78,186		142,375
Total	$	356,674	$	151,270	$	320,017	$	453,920	$	1,281,881

2013
Canada	$	25,502	$	45,954	$	109,361	$	34,260	$	215,077
Europe		168,394		62,825		108,644		153,807		493,670
Asia		103,931		8,134		65,622		136,934		314,621
Middle East		9,361		44,341		3,865		32,444		90,011
Rest of the world		17,856		11,865		26,716		82,956		139,393
Total	$	325,044	$	173,119	$	314,208	$	440,401	$	1,252,772

Quarterly Financial Data (Tables)

12 Months Ended

Dec. 31, 2015

Quarterly Financial Data [Abstract]

Quarterly Financial Data

	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
	(in thousands, except per share data)
2015
Net sales	$	865,281	$	889,541	$	883,933	$	943,640
Gross profit		518,161		533,911		533,483		579,091
Income from operations		246,896		251,974		250,371		278,677
Net earnings		155,773		171,280		160,417		208,597

Earnings from continuing operations per common share:
Basic		1.55		1.70		1.59		2.07
Diluted		1.54		1.69		1.58		2.05

2014
Net sales	$	834,052	$	885,175	$	884,122	$	946,145
Gross profit		488,936		523,182		524,040		565,741
Income from operations		223,400		246,666		245,658		283,749
Net earnings		147,226		157,361		155,510		185,936

Earnings from continuing operations per common share:
Basic		1.48		1.58		1.55		1.86
Diluted		1.46		1.56		1.54		1.84

Summary of Accounting Policies (Details) $ in Millions	12 Months Ended
Summary of Accounting Policies (Details) $ in Millions	Dec. 31, 2015 USD ($) ReportingUnit shares	Dec. 31, 2014 USD ($) shares	Dec. 31, 2013 USD ($) shares	Dec. 31, 2007 USD ($)
Summary of Accounting Policies [Abstract]
Cost Method Investments	$ 2.0			$ 11.5
Cost-method Investments, Other than Temporary Impairment	9.5
Retrospective effect of adoption of ASU on debt issuance costs on balance sheet		$ 13.0
Allowance for doubtful accounts and sales allowances	12.4	13.7
Cash Equivalents, at Carrying Value	$ 0.0	$ 40.0
Basic weighted-average shares outstanding (in shares) \| shares	100,616,000	99,916,000	99,123,000
Effect of potential common stock
Common stock awards (in shares) \| shares	887,000	816,000	891,000
Senior subordinated convertible notes (in shares) \| shares	94,000	152,000	195,000
Diluted shares outstanding (in shares) \| shares	101,597,000	100,884,000	100,209,000
Antidilutive stock options (in shares) \| shares	618,220	764,333	614,850
Foreign Currency Transaction Gain (Loss), before Tax	$ (0.7)	$ 0.2	$ (3.9)
Total goodwill reporting units \| ReportingUnit	32
Minimum carrying value of goodwill	$ 0.0
Maximum carrying value of goodwill	1,175.0
The approximate amount of earnings of foreign subsidiaries	1,250.0
Property, Plant and Equipment [Line Items]
Research and development costs	164.2	147.9	145.7
Contract revenue recognized under the percentage-of-completion method	253.0	266.0	$ 205.0
Capitalized software	$ 4.6	$ 4.7
Buildings [Member] \| Earliest [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	20 years
Buildings [Member] \| Latest [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	30 years
Machinery and equipment [Member] \| Earliest [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	8 years
Machinery and equipment [Member] \| Latest [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	12 years
Office Equipment [Member] \| Earliest [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Office Equipment [Member] \| Latest [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	5 years

Business Acquisitions (Details) $ in Thousands	12 Months Ended
Business Acquisitions (Details) $ in Thousands	Dec. 31, 2015 USD ($) Business	Dec. 31, 2014 USD ($) Business	Dec. 31, 2013 USD ($) Business
Business Acquisition [Line Items]
Number of business acquired \| Business	8	3	2
Fair value of assets acquired and liabilities assumed [Abstract]
Intangible Assets Other than Goodwill			$ 493,000
Goodwill	$ 5,824,726	$ 4,710,691	4,549,998
Intangibles acquired			493,000
Finite lived intangible assets			$ 465,000
Weighted average useful life			19 years
Cost of acquired entity transaction costs			$ 3,300
Trade Names [Member]
Fair value of assets acquired and liabilities assumed [Abstract]
Indefinite lived intangible assets			28,000
Customer Relationships [Member]
Fair value of assets acquired and liabilities assumed [Abstract]
Finite lived intangible assets			$ 451,000
Weighted average useful life			20 years
Technology [Member]
Fair value of assets acquired and liabilities assumed [Abstract]
Finite lived intangible assets			$ 12,000
Weighted average useful life			7 years
Noncompete Agreements [Member]
Fair value of assets acquired and liabilities assumed [Abstract]
Finite lived intangible assets			$ 2,000
Weighted average useful life			5 years
Immaterial Acquisitions [Member]
Business Acquisition [Line Items]
Cost of acquired entity purchase price	1,800,000	303,000
Fair value of assets acquired and liabilities assumed [Abstract]
Intangible Assets Other than Goodwill	731,000	99,000
Goodwill	1,200,000	208,000
Indefinite lived intangible assets	51,000	7,000
Intangibles acquired	731,000	99,000
Finite lived intangible assets	$ 680,000	$ 92,000
Weighted average useful life	17 years	17 years
Cost of acquired entity transaction costs	$ 5,900	$ 2,800
Immaterial Acquisitions [Member] \| Backlog [Member]
Fair value of assets acquired and liabilities assumed [Abstract]
Finite lived intangible assets		$ 1,000
Weighted average useful life		1 year
Immaterial Acquisitions [Member] \| Customer Relationships [Member]
Fair value of assets acquired and liabilities assumed [Abstract]
Finite lived intangible assets	$ 541,000	$ 82,000
Weighted average useful life	19 years	19 years
Immaterial Acquisitions [Member] \| Technology [Member]
Fair value of assets acquired and liabilities assumed [Abstract]
Finite lived intangible assets	$ 100,000	$ 7,000
Weighted average useful life	8 years	6 years
Immaterial Acquisitions [Member] \| Software [Member]
Fair value of assets acquired and liabilities assumed [Abstract]
Finite lived intangible assets	$ 39,000	$ 2,000
Weighted average useful life	6 years	4 years
Advanced Sensors, Ltd [Member]
Business Acquisition [Line Items]
Cost of acquired entity purchase price			$ 54,000
Fair value of assets acquired and liabilities assumed [Abstract]
Goodwill			28,000
Indefinite lived intangible assets			28,000
Managed Health Care Associates, Inc [Member]
Business Acquisition [Line Items]
Cost of acquired entity purchase price			1,000,000
Fair value of assets acquired and liabilities assumed [Abstract]
Current assets			59,813
Intangible Assets Other than Goodwill			465,500
Goodwill			678,183
Other assets			5,798
Total assets acquired			1,209,294
Current liabilities			(24,717)
Long-term deferred tax liability			(162,503)
Other liabilities			(6,524)
Net assets acquired			1,015,550
Fair value adjustment for admin fees related to customer purchases			35,000
Fair value liability related revenue-share obligation			8,600
Intangibles acquired			$ 465,500

Discontinued Operations and Disposal Groups (Details) - Abel Pumps LP [Member] - Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] € in Millions, $ in Millions	9 Months Ended	12 Months Ended
	Oct. 02, 2015 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)	Dec. 31, 2015 EUR (€)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Consideration		$ 106.0			€ 95
Disposal Group, Including Discontinued Operation, Description and Timing of Disposal		Abel Pumps, sold on 10/02/2015
Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group		Industrial Technology
Tax Expense related to gain on disposal group		$ 46.0
Future tax benefit related to sale of disposal group		11.0
Income (Loss) from Individually Significant Component Disposed of or Held-for-sale, Excluding Discontinued Operations, before Income Tax	$ 5.9		$ 10.3	$ 9.2
Other Income (Expense) [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal		$ 70.9

Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Inventories [Abstract]
Raw materials and supplies	$ 120,811	$ 124,103
Work in process	22,979	29,358
Finished products	80,118	79,184
Inventory reserves	(34,040)	(38,879)
Total Inventory	$ 189,868	$ 193,766

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Gross Property, Plant and Equipment	$ 401,086	$ 405,602
Accumulated Depreciation	(295,576)	(294,726)
Property, Plant and Equipment, Net	105,510	110,876
Depreciation expense	38,185	40,890	$ 37,756
Land [Member]
Property, Plant and Equipment [Line Items]
Gross Property, Plant and Equipment	2,488	4,130
Buildings [Member]
Property, Plant and Equipment [Line Items]
Gross Property, Plant and Equipment	79,182	80,775
Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Property, Plant and Equipment	$ 319,416	$ 320,697

Goodwill and Other Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Goodwill [Line Items]
Balances	$ 4,710,691	$ 4,549,998
Goodwill acquired	1,196,451	207,943
Goodwill related to divestiture of business	(20,524)
Currency translation adjustments	(62,016)	(50,488)
Reclassification and other	124	3,238
Balances	5,824,726	4,710,691	$ 4,549,998
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	3,312,795	2,738,747
Accumulated amortization	(783,799)	(760,018)
Net book value	2,528,996	1,978,729
Amortization expense of other intangible assets	164,000	153,000	147,000
Expected Amortization expense [Abstract]
2016	188,000
2017	178,000
2018	170,000
2019	162,000
2020	156,000
Assets subject to amortization \| Customer Relationships [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	2,448,509	1,975,334
Accumulated amortization	(602,615)	(543,594)
Net book value	1,845,894	1,431,740
Assets subject to amortization \| Unpatented Technology [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	270,170	217,260
Accumulated amortization	(117,405)	(134,702)
Net book value	152,765	82,558
Assets subject to amortization \| Software [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	161,201	156,449
Accumulated amortization	(44,298)	(62,882)
Net book value	116,903	93,567
Assets subject to amortization \| Patents and other protective rights Memeber
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	24,160	26,463
Accumulated amortization	(18,659)	(18,325)
Net book value	5,501	8,138
Assets subject to amortization \| Backlog [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	700	1,100
Accumulated amortization	(700)	(443)
Net book value	0	657
Assets subject to amortization \| Trade Names [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	595	622
Accumulated amortization	(122)	(72)
Net book value	473	550
Assets not subject to amortization \| Trade Names [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	407,460	361,519
Accumulated amortization	0	0
Net book value	407,460	361,519
Medical And Scientific Imaging
Goodwill [Line Items]
Balances	2,594,356	2,435,506
Goodwill acquired	476,106	174,347
Goodwill related to divestiture of business	0
Currency translation adjustments	(31,556)	(18,847)
Reclassification and other	291	3,350
Balances	3,039,197	2,594,356	2,435,506
RF Technology
Goodwill [Line Items]
Balances	1,280,788	1,254,294
Goodwill acquired	720,345	33,596
Goodwill related to divestiture of business	0
Currency translation adjustments	(7,667)	(7,102)
Reclassification and other	(167)	0
Balances	1,993,299	1,280,788	1,254,294
Industrial Technology
Goodwill [Line Items]
Balances	408,964	425,501
Goodwill acquired	0	0
Goodwill related to divestiture of business	(20,524)
Currency translation adjustments	(14,407)	(16,537)
Reclassification and other	0	0
Balances	374,033	408,964	425,501
Energy Systems And Controls
Goodwill [Line Items]
Balances	426,583	434,697
Goodwill acquired	0	0
Goodwill related to divestiture of business	0
Currency translation adjustments	(8,386)	(8,002)
Reclassification and other	0	(112)
Balances	$ 418,197	$ 426,583	$ 434,697

Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accrued Liabilities [Abstract]
Commissions	$ 12,079	$ 12,025
Warranty	10,183	9,537	$ 14,336	$ 9,755
Accrued dividend	30,436	25,032
Billings in excess of cost	5,464	14,135
Customer deposits	15,094	16,392
Interest	19,776	18,275
Rebates	16,511	12,968
Other	58,970	52,374
Total	$ 168,513	$ 160,738

Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract]
United States	$ 710,614	$ 665,219	$ 517,432
Other	291,731	256,237	236,698
Earnings Before Income Taxes	1,002,345	921,456	754,130
Current:
Federal	229,224	218,302	166,430
State	22,041	37,155	12,577
Foreign	71,507	56,107	40,451
Deferred:
Federal	(10,134)	(30,664)	(1,965)
Foreign	(6,360)	(5,477)	(1,656)
Total Income Taxes	$ 306,278	$ 275,423	$ 215,837
Federal Statutory Tax Rate Reconciliation
Federal statutory rate (in hundredths)	35.00%	35.00%	35.00%
Foreign rate differential (in hundredths)	(3.30%)	(3.90%)	(4.10%)
R&D tax credits (in hundredths)	(0.50%)	(0.40%)	(0.50%)
State taxes, net of federal benefit (in hundredths)	2.00%	2.00%	1.90%
Foreign tax credits (in hundredths)	0.00%	0.00%	0.00%
Section 199 deduction (in hundredths)	(1.30%)	(1.60%)	(1.80%)
Other, net (in hundredths)	(1.30%)	(1.20%)	(1.90%)
Effective Rate (in hundredths)	30.60%	29.90%	28.60%
Deferred tax assets:
Reserves and accrued expenses	$ 146,014	$ 130,508
Inventories	9,309	10,186
Net operating loss carryforwards	45,616	41,480
R&D credits	8,504	7,145
Foreign tax credits	7,940	0
Valuation allowance	(19,338)	(16,169)
Total deferred tax assets	198,045	173,150
Deferred tax liabilities:
Reserves and accrued expenses	11,222	27,981
Amortizable intangible assets	962,143	798,502
Plant and equipment	4,004	4,741
Total deferred tax liabilities	977,369	831,224
Reconciliation of Unrecognized Tax Benefits [Roll Forward]
Beginning balance	28,567	26,924	$ 24,865
Additions for tax positions of prior periods	3,525	6,532	3,055
Additions for tax positions of the current period	3,299	5,571	1,639
Additions due to acquisitions	6,177	0	5,026
Reductions for tax positions of prior periods	(12,206)	(1,008)	(3,675)
Settlements with taxing authorities	(142)	(518)	0
Lapse of applicable statute of limitations	(3,080)	(8,934)	(3,986)
Ending balance	26,140	28,567	$ 26,924
Unrecognized income tax benefits that, if recognized, would affect the effective income tax rate in any future periods	24,200
Interest and penalties related to unrecognized tax benefits	(1,800)
Accrued interest and penalties	3,400	$ 5,200
Reduction in unrecognized tax benefits expected within twelve months of the balance sheet date	3,200
Internal Revenue Service (IRS) [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	17,500
Operating Loss Carryforwards, Valuation Allowance	$ 11,000
Internal Revenue Service (IRS) [Member] \| Earliest [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carryover expiration date	Dec. 31, 2023
Internal Revenue Service (IRS) [Member] \| Latest [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carryover expiration date	Dec. 31, 2035
Foreign Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 13,100
Operating Loss Carryforwards, Valuation Allowance	$ 8,300
Foreign Tax Authority [Member] \| Earliest [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carryover expiration date	Dec. 31, 2016
State and Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 22,900
State and Local Jurisdiction [Member] \| Earliest [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carryover expiration date	Dec. 31, 2016
State and Local Jurisdiction [Member] \| Latest [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carryover expiration date	Dec. 31, 2035
Research Tax Credit Carryforward [Member]
Operating Loss Carryforwards [Line Items]
Tax Credit Carryforward, Amount	$ 12,400
Research Tax Credit Carryforward [Member] \| Earliest [Member]
Operating Loss Carryforwards [Line Items]
Tax Credit Carryforward, Expiration Date	Dec. 31, 2019
Research Tax Credit Carryforward [Member] \| Latest [Member]
Operating Loss Carryforwards [Line Items]
Tax Credit Carryforward, Expiration Date	Dec. 31, 2035
Foreign Tax Credit Carryforward [Member]
Operating Loss Carryforwards [Line Items]
Tax Credit Carryforward, Amount	$ 7,900
Foreign Tax Credit Carryforward [Member] \| Latest [Member]
Operating Loss Carryforwards [Line Items]
Tax Credit Carryforward, Expiration Date	Dec. 31, 2025

Long-Term Debt (Details) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2015 USD ($) TradingDays / d shares $ / shares	Dec. 31, 2014 USD ($)
Line of Credit Facility [Line Items]
Line of Credit Facility, Current Borrowing Capacity	$ 1,850,000
Line of Credit Facility, Borrowing Capacity, Term	5 years
Increase in revolver capacity	$ 350,000
Line of Credit Facility, Initiation Date	Jul. 27, 2012
Line of Credit Facility, Expiration Date	Jul. 27, 2017
Line of Credit Facility, Amount Outstanding	$ 180,000
Outstanding letters of credit	$ 43,300
Debt covenant compliance	3.5
Debt Instrument [Line Items]
Total Debt	$ 3,271,222	$ 2,201,374
Unamortized Debt Issuance Expense	(17,392)	(12,749)
Current Portion	6,805	11,092
Long-term debt, net of current portion	3,264,417	2,190,282
Principal amount	3,100
Future maturities of long term debt [Abstract]
2016	6,805
2017	581,296
2018	800,460
2019	500,053
2020	600,000
Thereafter	800,000
Total	3,288,614
Credit Facility Member 2012 [Member]
Debt Instrument [Line Items]
Principal amount	$ 180,000	0
Senior Notes 2017 [Member]
Debt Instrument [Line Items]
Issuance Date	Nov. 21, 2012
Interest rate (in hundredths)	1.85%
Principal amount	$ 400,000	400,000
Periodic interest payments	semi-annually
Periodic interest payments, start	May 15, 2013
Maturity Date	Nov. 15, 2017
Senior Notes 2018 [Member]
Debt Instrument [Line Items]
Issuance Date	Jun. 06, 2013
Interest rate (in hundredths)	2.05%
Principal amount	$ 800,000	800,000
Periodic interest payments	semi-annually
Periodic interest payments, start	October 1, 2013
Maturity Date	Oct. 01, 2018
Senior Notes 2019 [Member]
Debt Instrument [Line Items]
Issuance Date	Sep. 15, 2009
Interest rate (in hundredths)	6.25%
Principal amount	$ 500,000	500,000
Periodic interest payments	semi-annually
Periodic interest payments, start	March 1, 2010
Maturity Date	Sep. 01, 2019
Senior Notes 2020 [Member]
Debt Instrument [Line Items]
Issuance Date	Dec. 07, 2015
Interest rate (in hundredths)	3.00%
Principal amount	$ 600,000	0
Periodic interest payments	semi-annually
Periodic interest payments, start	June 15, 2016
Maturity Date	Dec. 15, 2020
Senior Notes 2022 [Member]
Debt Instrument [Line Items]
Issuance Date	Nov. 21, 2012
Interest rate (in hundredths)	3.125%
Principal amount	$ 500,000	500,000
Periodic interest payments	semi-annually
Periodic interest payments, start	May 15, 2013
Maturity Date	Nov. 15, 2022
Senior Notes 2025 [Member]
Debt Instrument [Line Items]
Issuance Date	Dec. 07, 2015
Interest rate (in hundredths)	3.85%
Principal amount	$ 300,000	0
Periodic interest payments	semi-annually
Periodic interest payments, start	June 15, 2016
Maturity Date	Dec. 15, 2025
Convertible Notes [Member]
Debt Instrument [Line Items]
Principal amount	$ 4,179	8,003
Capital Lease Obligations And Foreign Letter Of Credit Issuance [Member]
Debt Instrument [Line Items]
Principal amount	$ 4,435	$ 6,120
Senior Subordinated Notes [Member]
Debt Instrument [Line Items]
Interest rate (in hundredths)	3.75%
Maturity Date	Dec. 31, 2034
Subordinated Convertible Notes
Subordinated convertible notes, original public offering amount	$ 230,000
Original issue discount (in hundredths)	60.498%
Subordinated convertible note holding period for contingent cash interest	180
Trading days the average price of subordinated convertible note must meet threshold within six months measurement period	5
Commencement date for measurement of average trading price on a subordinated convertible note	Jan. 15, 2009
Contingent cash interest payable annual rate if threshold is met (in hundredths)	0.25%
Debt Instrument Convertible Price Next Conversion Date \| $ / shares	$ 572.76
Next conversion date	1/15/2019
Convertible notes purchase price on January 15, 2019 (third conversion date) \| $ / shares	$ 689.68
Third conversion date	1/15/2024
Convertible notes purchase price on January 15, 2024 (fourth conversion date) \| $ / shares	$ 830.47
Fourth conversion date	1/15/2029
Minimum number of trading days in the consecutive trading period that the common stock sale price above threshold to trigger conversion (in days) \| TradingDays / d	20
Number of consecutive trading days in the preceding quarter the minimum trading days must occur in for the sale price to reach threshold to trigger conversion (in days) \| TradingDays / d	30
Conversion price, end of period \| $ / shares	$ 511.62
If converted, the value exceeding principal amount outstanding at end of period	$ 16,000
If converted, issuance of common stock shares \| shares	81,778

Fair Value (Details) $ in Millions	Dec. 31, 2015 USD ($)
Fair value debt instruments [Line Items]
Face Value of Debt Instrument	$ 3.1
Convertible Notes [Member]
Fair value debt instruments [Line Items]
Fair value of debt instrument	4.0
Fair Value, Inputs, Level 2 [Member]
Fair value debt instruments [Line Items]
Face Value of Debt Instrument	3.1
Fair Value, Inputs, Level 2 [Member] \| Senior notes due 2017 [Member]
Fair value debt instruments [Line Items]
Face Value of Debt Instrument	400.0
Long-term Debt, Fair Value	398.0
Fair Value, Inputs, Level 2 [Member] \| Senior notes due 2018 [Member]
Fair value debt instruments [Line Items]
Face Value of Debt Instrument	800.0
Long-term Debt, Fair Value	795.0
Fair Value, Inputs, Level 2 [Member] \| Senior notes due 2019 [Member]
Fair value debt instruments [Line Items]
Face Value of Debt Instrument	500.0
Long-term Debt, Fair Value	553.0
Fair Value, Inputs, Level 2 [Member] \| Senior Notes 2020 [Member]
Fair value debt instruments [Line Items]
Face Value of Debt Instrument	600.0
Long-term Debt, Fair Value	599.0
Fair Value, Inputs, Level 2 [Member] \| Senior notes due 2022 [Member]
Fair value debt instruments [Line Items]
Face Value of Debt Instrument	500.0
Long-term Debt, Fair Value	488.0
Fair Value, Inputs, Level 2 [Member] \| Senior Notes 2025 [Member]
Fair value debt instruments [Line Items]
Face Value of Debt Instrument	300.0
Long-term Debt, Fair Value	$ 304.0

Retirement and Other Benefit Plans (Details) $ in Millions	12 Months Ended
Retirement and Other Benefit Plans (Details) $ in Millions	Dec. 31, 2015 USD ($) Agreement	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Retirement and Other Benefit Plans [Abstract]
Number of defined contribution plans maintained by the company \| Agreement	4
Defined contribution retirement plan cost \| $	$ 20.4	$ 19.5	$ 16.5

Stock-Based Compensation (Details) - USD ($)	12 Months Ended
Stock-Based Compensation (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of eligible earnings to purchase common stock through the employee stock purchase plan (in hundredths)	10.00%
Discount rate to the average closing price at which employees may purchase stock (in hundredths)	5.00%
Stock based compensation expense	$ 61,800,000	$ 63,000,000	$ 53,400,000
Tax effect recognized in net income	21,600,000	22,100,000	18,700,000
Windfall tax benefit, net	$ 22,200,000	$ 21,500,000	$ 16,000,000
Weighted average assumptions used in calculating the weighted average fair value of options granted
Weighted average fair value of options granted (per share)	$ 33.98	$ 34.95	$ 37.08
Risk-free interest rate (%) (in hundredths)	1.53%	1.63%	0.86%
Average expected option life (in years)	5 years 1 month 6 days	5 years 2 months 19 days	5 years 2 months 8 days
Expected volatility (%) (in hundredths)	22.17%	27.01%	36.09%
Expected dividend yield (%) (in hundredths)	0.62%	0.58%	0.56%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of shares outstanding, beginning balance (in shares)	2,981,111	2,988,436
Number of shares granted (in shares)	628,155	650,000
Options Exercised (in shares)	(400,050)	(587,661)
Number of shares canceled (in shares)	(91,600)	(69,664)
Number of shares outstanding, ending balance (in shares)	3,117,616	2,981,111	2,988,436
Number of shares, options, exercisable, number (in shares)	1,935,351
Weighted Average Exercise Price [Abstract]
Weighted average exercise price per share outstanding, beginning balance (in dollars per share)	$ 90.48	$ 74.00
Weighted average exercise price per share granted (in dollars per share)	162.77	137.05
Weighted average exercise price per share exercised (in dollars per share)	82.50	55.98
Weighted average exercise price per share cancelled (in dollars per share)	142.36	116.29
Weighted average exercise price per share outstanding, ending balance (in dollars per share)	$ 104.54	$ 90.48	$ 74.00
Weighted average remaining contractual term of options outstanding (in years)	6 years 29 days	6 years 4 months 13 days
Aggregate intrinsic value of options outstanding	$ 265,782,636	$ 196,378,239
Options, Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 78.76
Options, Exercisable, Weighted Average Remaining Contractual Term (in years)	4 years 6 months 18 days
Options, Exercisable, Aggregate intrinsic value	$ 214,879,670
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Total unrecognized compensation expense related to nonvested restricted stock granted to both employees and directors	$ 26,500,000
Weighted-average period over which unrecognized compensation costs on non-vested stock options are expected to be recognized (in years)	1 year 10 months 24 days
Intrinsic value of options exercised	$ 36,900,000	50,300,000	$ 28,800,000
Cash received from option exercises under all plans	$ 33,000,000	$ 32,500,000
Summary of nonvested shares activity [Rollforward]
Non-vested shares outstanding, beginning of period (in shares)	542,555	573,850
Nonvested shares granted (in shares)	437,035	375,060
Nonvested shares vested (in shares)	(243,423)	(378,994)
Nonvested shares forfeited (in shares)	(26,892)	(27,361)
Nonvested shares outstanding, end of period (in shares)	709,275	542,555	573,850
Restricted Stock Awards [Abstract]
Weighted average fair value of nonvested shares, beginning of period (in dollars per share)	$ 130.29	$ 103.44
Weighted Average Restricted Award Grant Date Fair Value (in dollars per share)	159.32	142.30
Weighted average fair value of shares vested (in dollars per share)	183.10	153.16
Weighted average fair value of nonvested shares forfeited (in dollars per share)	148.82	106.60
Weighted average fair value of nonvested shares, end of period (in dollars per share)	$ 183.90	$ 130.29	$ 103.44
Total unrecognized compensation expense related to nonvested restricted stock granted to both employees and directors	$ 62,200,000
Restricted Awards Outstanding, Weighted Average Remaining Contractual Terms	2 years 4 months 24 days
Employee Stock Purchase Plan
Shares of stock purchased during the period by participants in the employee stock purchase plan (in shares)	18,132	20,368	20,211
Amount paid for stock purchased during the period by participants in the employee stock purchase plan	$ 2,900,000	$ 2,800,000	$ 2,400,000
Employee Stock Ownership Plan (ESOP), Compensation Expense	$ 0	0	0
Earliest [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of market value at which stock option are granted (in hundredths)	100.00%
Employee Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	$ 15,300,000	16,600,000	16,900,000
Expiration period (in years)	10 years
Employee Stock Options [Member] \| Earliest [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	3 years
Employee Stock Options [Member] \| Latest [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	5 years
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	$ 46,500,000	$ 46,400,000	$ 36,500,000
Restricted Stock [Member] \| Earliest [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	1 year
Restricted Stock [Member] \| Latest [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	3 years
Exercise Price Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit (in dollars per share)	$ 38.46
Exercise price range, upper range limit (in dollars per share)	$ 57.68
Options outstanding (in shares)	896,590
Average exercise price of options outstanding (in dollars per share)	$ 53.04
Average remaining life of options outstanding (in years)	2 years 4 months 24 days
Exercisable options (in shares)	896,590
Average exercise price of exercisable options (in dollars per share)	$ 53.04
Exercise Price Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit (in dollars per share)	57.69
Exercise price range, upper range limit (in dollars per share)	$ 76.91
Options outstanding (in shares)	298,733
Average exercise price of options outstanding (in dollars per share)	$ 72.65
Average remaining life of options outstanding (in years)	5 years 1 month 6 days
Exercisable options (in shares)	298,733
Average exercise price of exercisable options (in dollars per share)	$ 72.65
Exercise Price Range 3 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit (in dollars per share)	76.92
Exercise price range, upper range limit (in dollars per share)	$ 96.14
Options outstanding (in shares)	295,684
Average exercise price of options outstanding (in dollars per share)	$ 93.16
Average remaining life of options outstanding (in years)	6 years 1 month 6 days
Exercisable options (in shares)	294,434
Average exercise price of exercisable options (in dollars per share)	$ 93.15
Exercise Price Range 4 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit (in dollars per share)	96.15
Exercise price range, upper range limit (in dollars per share)	$ 115.37
Options outstanding (in shares)	310,597
Average exercise price of options outstanding (in dollars per share)	$ 114.82
Average remaining life of options outstanding (in years)	7 years
Exercisable options (in shares)	200,319
Average exercise price of exercisable options (in dollars per share)	$ 114.60
Exercise Price Range 5 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit (in dollars per share)	115.38
Exercise price range, upper range limit (in dollars per share)	$ 134.60
Options outstanding (in shares)	562,626
Average exercise price of options outstanding (in dollars per share)	$ 130.96
Average remaining life of options outstanding (in years)	8 years
Exercisable options (in shares)	195,520
Average exercise price of exercisable options (in dollars per share)	$ 130.52
Exercise Price Range 6 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit (in dollars per share)	134.61
Exercise price range, upper range limit (in dollars per share)	$ 153.82
Options outstanding (in shares)	272,036
Average exercise price of options outstanding (in dollars per share)	$ 144.28
Average remaining life of options outstanding (in years)	8 years 8 months 12 days
Exercisable options (in shares)	37,422
Average exercise price of exercisable options (in dollars per share)	$ 142.12
Exercise Price Range 7 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit (in dollars per share)	153.83
Exercise price range, upper range limit (in dollars per share)	$ 173.05
Options outstanding (in shares)	413,350
Average exercise price of options outstanding (in dollars per share)	$ 165.00
Average remaining life of options outstanding (in years)	9 years 2 months 12 days
Exercisable options (in shares)	11,000
Average exercise price of exercisable options (in dollars per share)	$ 156.57
Exercise Price Range 8 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit (in dollars per share)	173.06
Exercise price range, upper range limit (in dollars per share)	$ 192.28
Options outstanding (in shares)	68,000
Average exercise price of options outstanding (in dollars per share)	$ 181.14
Average remaining life of options outstanding (in years)	9 years 8 months 12 days
Exercisable options (in shares)	1,333
Average exercise price of exercisable options (in dollars per share)	$ 175.00
Exercise Price Range 9 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit (in dollars per share)	38.46
Exercise price range, upper range limit (in dollars per share)	$ 192.28
Options outstanding (in shares)	3,117,616
Average exercise price of options outstanding (in dollars per share)	$ 104.54
Average remaining life of options outstanding (in years)	6 years 1 month 6 days
Exercisable options (in shares)	1,935,351
Average exercise price of exercisable options (in dollars per share)	$ 78.76
2006 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved for issuance	14,000,000
Shares available for grant (in shares)	3,175,605
2000 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved for issuance	17,000

Contingencies (Details) - USD ($) $ in Thousands	12 Months Ended
Contingencies (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Contingencies [Abstract]
Rent expense	$ 40,200	$ 38,400	$ 39,800
Future mimimum property lease commitments [Abstract]
2016	36,700
2017	31,100
2018	20,600
2019	14,300
2020	11,600
Thereafter	32,500
Total future minimum property lease commitments	146,800
Product Warranty Disclosure [Abstract]
Balance at beginning of year	9,537	14,336	9,755
Additions charged to costs and expenses	14,284	13,396	20,387
Deductions	(13,059)	(18,078)	(15,697)
Other	(579)	(117)	(109)
Balance at end of year	10,183	$ 9,537	$ 14,336
Outstanding surety bonds	$ 505,000

Segment and Geographic Area Information (Details)
$ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2015

USD ($)

Sep. 30, 2015

USD ($)

Jun. 30, 2015

USD ($)

Mar. 31, 2015

USD ($)

Dec. 31, 2014

USD ($)

Sep. 30, 2014

USD ($)

Jun. 30, 2014

USD ($)

Mar. 31, 2014

USD ($)

Dec. 31, 2015

USD ($)

Segment

Dec. 31, 2014

USD ($)

Dec. 31, 2013

USD ($)

Business Segments [Abstract]

Number of operating segments | Segment

Schedule of Segment Reporting Information, by Segment [Line Items]

Net sales

$ 943,640

$ 883,933

$ 889,541

$ 865,281

$ 946,145

$ 884,122

$ 885,175

$ 834,052

$ 3,582,395

$ 3,549,494

$ 3,238,128

Operating profit

278,677

$ 250,371

$ 251,974

$ 246,896

283,749

$ 245,658

$ 246,666

$ 223,400

1,027,918

999,473

842,361

Assets:

Operating assets

945,046

949,239

945,046

949,239

966,463

Intangible assets, net

8,353,722

6,689,420

8,353,722

6,689,420

6,589,134

Other

869,597

761,526

869,597

761,526

613,523

Total

10,168,365

8,400,185

10,168,365

8,400,185

8,169,120

Capital expenditures

36,260

37,644

42,528

Depreciation and other amortization

204,261

197,284

189,190

Medical and Scientific Imaging [Member]

Schedule of Segment Reporting Information, by Segment [Line Items]

Net sales

1,215,318

1,080,309

902,281

Operating profit

441,931

375,867

268,172

Assets:

Operating assets

265,520

232,380

265,520

232,380

237,681

Intangible assets, net

4,451,028

3,842,180

4,451,028

3,842,180

3,682,465

Other

121,461

147,529

121,461

147,529

152,211

Capital expenditures

12,642

11,430

10,231

Depreciation and other amortization

105,928

93,683

85,177

RF Technology [Member]

Schedule of Segment Reporting Information, by Segment [Line Items]

Net sales

1,033,951

950,227

904,363

Operating profit

312,112

271,177

253,532

Assets:

Operating assets

293,004

270,458

293,004

270,458

266,026

Intangible assets, net

2,848,911

1,720,977

2,848,911

1,720,977

1,725,597

Other

117,596

65,636

117,596

65,636

62,576

Capital expenditures

10,758

10,521

10,190

Depreciation and other amortization

56,877

58,702

60,590

Industrial Technology [Member]

Schedule of Segment Reporting Information, by Segment [Line Items]

Net sales

745,381

827,145

779,564

Operating profit

214,538

247,596

223,053

Assets:

Operating assets

182,544

220,115

182,544

220,115

232,505

Intangible assets, net

513,155

557,593

513,155

557,593

583,822

Other

67,832

120,681

67,832

120,681

75,215

Capital expenditures

9,179

10,713

17,043

Depreciation and other amortization

19,912

21,135

21,551

Energy Systems And Controls [Member]

Schedule of Segment Reporting Information, by Segment [Line Items]

Net sales

587,745

691,813

651,920

Operating profit

162,128

203,021

183,679

Assets:

Operating assets

194,898

219,284

194,898

219,284

214,926

Intangible assets, net

540,628

568,670

540,628

568,670

597,250

Other

113,014

223,831

113,014

223,831

167,879

Capital expenditures

3,276

4,634

4,952

Depreciation and other amortization

21,254

23,281

21,353

Corporate [Member]

Schedule of Segment Reporting Information, by Segment [Line Items]

Net sales

Operating profit

(102,791)

(98,188)

(86,075)

Assets:

Operating assets

9,080

7,002

9,080

7,002

15,325

Intangible assets, net

Other

$ 449,694

$ 203,849

^[1]

449,694

203,849

^[1]

155,642

^[1]

Capital expenditures

405

346

112

Depreciation and other amortization

$ 290

$ 483

$ 519

[1]	Other assets have been adjusted due to the adoption of a recent ASU regarding presentation of debt issuance costs (see Note 1). These adjustments were $12,749 and $15,861 for the years ended December 31, 2014 and 2013, respectively.

Segment and Geographic Area Information, Sales by Country of Origin (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Net sales	$ 943,640	$ 883,933	$ 889,541	$ 865,281	$ 946,145	$ 884,122	$ 885,175	$ 834,052	$ 3,582,395	$ 3,549,494	$ 3,238,128
Long Lived Assets	155,482				165,636				155,482	165,636	171,423
Export sales [Abstract]
Export sales from the United States									$ 481,000	477,000	479,000
Geographic Areas, Revenues from External Customers [Abstract]
Minimum percent of total sales generated in Canada									5.00%
Sales to Customers Outside the US									$ 1,162,058	1,281,881	1,252,772
Sales [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Sales to unaffiliated customers									3,582,395	3,549,494	3,238,128
Sales between geographic areas									0	0	0
Net sales									3,582,395	3,549,494	3,238,128
United States [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Long Lived Assets	133,522				134,855				133,522	134,855	135,157
United States [Member] \| Sales [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Sales to unaffiliated customers									2,829,752	2,661,470	2,400,592
Sales between geographic areas									135,363	159,049	141,529
Net sales									$ 2,965,115	2,820,519	2,542,121
Canada [Member]
Export sales [Abstract]
Export sales from the United States (in hundredths)									15.00%
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									$ 158,952	209,237	215,077
Europe [Member]
Export sales [Abstract]
Export sales from the United States (in hundredths)									17.00%
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									$ 452,238	518,893	493,670
Non US Operations [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Long Lived Assets	21,960				30,781				21,960	30,781	36,266
Non US Operations [Member] \| Sales [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Sales to unaffiliated customers									752,643	888,024	837,536
Sales between geographic areas									119,006	119,175	121,431
Net sales									871,649	1,007,199	958,967
Eliminations [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Long Lived Assets	$ 0				$ 0				0	0	0
Eliminations [Member] \| Sales [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Sales to unaffiliated customers									0	0	0
Sales between geographic areas									(254,369)	(278,224)	(262,960)
Net sales									$ (254,369)	(278,224)	(262,960)
Asia [Member]
Export sales [Abstract]
Export sales from the United States (in hundredths)									36.00%
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									$ 315,656	320,326	314,621
Middle East [Member]
Export sales [Abstract]
Export sales from the United States (in hundredths)									18.00%
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									$ 124,489	91,050	90,011
Rest of the World [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									$ 110,723	142,375	139,393
South Pacific [Member]
Export sales [Abstract]
Export sales from the United States (in hundredths)									3.00%
South America [Member]
Export sales [Abstract]
Export sales from the United States (in hundredths)									5.00%
Other Geographical Area [Member]
Export sales [Abstract]
Export sales from the United States (in hundredths)									6.00%
Medical and Scientific Imaging [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Net sales									$ 1,215,318	1,080,309	902,281
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									340,461	356,674	325,044
Medical and Scientific Imaging [Member] \| Canada [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									23,737	24,997	25,502
Medical and Scientific Imaging [Member] \| Europe [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									167,698	185,263	168,394
Medical and Scientific Imaging [Member] \| Asia [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									112,732	107,695	103,931
Medical and Scientific Imaging [Member] \| Middle East [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									15,877	9,997	9,361
Medical and Scientific Imaging [Member] \| Rest of the World [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									20,417	28,722	17,856
RF Technology [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Net sales									1,033,951	950,227	904,363
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									178,032	151,270	173,119
RF Technology [Member] \| Canada [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									45,506	45,811	45,954
RF Technology [Member] \| Europe [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									57,581	54,330	62,825
RF Technology [Member] \| Asia [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									10,019	7,555	8,134
RF Technology [Member] \| Middle East [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									54,165	34,241	44,341
RF Technology [Member] \| Rest of the World [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									10,761	9,333	11,865
Industrial Technology [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Net sales									745,381	827,145	779,564
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									253,272	320,017	314,208
Industrial Technology [Member] \| Canada [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									65,826	106,598	109,361
Industrial Technology [Member] \| Europe [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									97,938	121,909	108,644
Industrial Technology [Member] \| Asia [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									60,817	61,552	65,622
Industrial Technology [Member] \| Middle East [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									4,220	3,824	3,865
Industrial Technology [Member] \| Rest of the World [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									24,471	26,134	26,716
Energy Systems And Controls [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Net sales									587,745	691,813	651,920
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									390,293	453,920	440,401
Energy Systems And Controls [Member] \| Canada [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									23,883	31,831	34,260
Energy Systems And Controls [Member] \| Europe [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									129,021	157,391	153,807
Energy Systems And Controls [Member] \| Asia [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									132,088	143,524	136,934
Energy Systems And Controls [Member] \| Middle East [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									50,227	42,988	32,444
Energy Systems And Controls [Member] \| Rest of the World [Member]
Geographic Areas, Revenues from External Customers [Abstract]
Sales to Customers Outside the US									55,074	78,186	82,956
Corporate [Member]
Schedule of Entity Wide Information About Geographic Areas [Line Items]
Net sales									$ 0	$ 0	$ 0

Quarterly Financial Data (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Quarterly Financial Data [Abstract]
Net sales	$ 943,640	$ 883,933	$ 889,541	$ 865,281	$ 946,145	$ 884,122	$ 885,175	$ 834,052	$ 3,582,395	$ 3,549,494	$ 3,238,128
Gross profit	579,091	533,483	533,911	518,161	565,741	524,040	523,182	488,936	2,164,646	2,101,899	1,882,928
Income from operations	278,677	250,371	251,974	246,896	283,749	245,658	246,666	223,400	1,027,918	999,473	842,361
Net earnings	$ 208,597	$ 160,417	$ 171,280	$ 155,773	$ 185,936	$ 155,510	$ 157,361	$ 147,226	$ 696,067	$ 646,033	$ 538,293
Earnings from continuing operations per common share:
Basic (in dollars per share)	$ 2.07	$ 1.59	$ 1.70	$ 1.55	$ 1.86	$ 1.55	$ 1.58	$ 1.48	$ 6.92	$ 6.47	$ 5.43
Diluted (in dollars per share)	$ 2.05	$ 1.58	$ 1.69	$ 1.54	$ 1.84	$ 1.54	$ 1.56	$ 1.46	$ 6.85	$ 6.40	$ 5.37

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Subsequent Events (Details) $ in Millions	Feb. 26, 2016 USD ($)
Subsequent Event [Member]
Subsequent Event [Line Items]
Aggregate purchase price for acquisitions	$ 170

Schedule II - Consolidated Valuation and Qualifying Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Allowance For Doubtful Accounts And Sales Allowances [Member]
Valuation and Qualifying Accounts Roll Forward]
Balance at beginning of year	$ 13,694	$ 14,992	$ 15,976
Additions charged to costs and expenses	1,536	2,357	1,350
Deductions	(4,128)	(3,355)	(2,992)
Other changes	1,302	(300)	658
Balance at end of year	12,404	13,694	14,992
Reserve for inventory obsolescence [Member]
Valuation and Qualifying Accounts Roll Forward]
Balance at beginning of year	38,879	43,452	41,967
Additions charged to costs and expenses	8,616	8,621	11,360
Deductions	(9,049)	(11,833)	(9,696)
Other changes	(4,406)	(1,361)	(179)
Balance at end of year	$ 34,040	$ 38,879	$ 43,452